{
  "meta": {
    "title": "00049_Late_Night_Pyq_Pyt_Marathon_-_49",
    "url": "https://brainandscalpel.vercel.app/00049-late-night-pyq-pyt-marathon-49-dcf3b2a5.html",
    "scrapedAt": "2025-11-29T17:24:56.892Z"
  },
  "questions": [
    {
      "id": 13096,
      "choices": [
        {
          "id": 52346,
          "text": "<p><span style=\"font-size:12.0pt;\">Mild non-proliferative diabetic retinopathy</span></p>"
        },
        {
          "id": 52347,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿Severe non-proliferative diabetic retinopathy</span></p>"
        },
        {
          "id": 52348,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿Bird shot choroidopathy</span></p>"
        },
        {
          "id": 52349,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿Proliferative diabetic retinopathy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 60-year-old diabetic male presents with a history of decreased vision. Fluorescein angiography showed the following image. What is the most likely diagnosis? (</span>AIIMS Nov 2017)</p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/25/inicet-ophtha-13.jpg\" alt=\"\" width=\"300\" height=\"412\"></p>",
      "unique_key": "Q6540706",
      "question_audio": null,
      "question_video": null,
      "map_id": 13399309,
      "difficulty_level": "intermediate",
      "subjects_id": [
        8
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Proliferative diabetic retinopathy</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Image shows neovascularization in proliferative diabetic retinopathy, arising from optic nerve head.</span></li><li><span style=\"font-size:12.0pt;\">Neovascularization of the disc (ND). and along large vessels, as well as neovascularization elsewhere (NVE) present.</span></li><li><span style=\"font-size:12.0pt;\">Treatment for proliferative diabetic retinopathy is photocoagulation of ischaemic areas.</span></li><li><span style=\"font-size:12.0pt;\">Aim is to reduce metabolic demand and prevent release of vasoproliferative factors.</span></li></ul><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/27/diabetic-retinopathy.jpeg\" alt=\"\" width=\"590\" height=\"283\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Birdshot retinochoroidopathy (also known as birdshot chorioretinopathy, vitiliginous chorioretinitis, or simply birdshot uveitis) is a chronic, bilateral, posterior uveitis with characteristic yellow-white lesions in the fundus.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Mild Non-proliferative Diabetic Retinopathy</strong> - Characterized by microaneurysms and retinal hemorrhages but does not feature neovascularization.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Severe Non-proliferative Diabetic Retinopathy</strong> - More extensive than mild, including hemorrhages, microaneurysms, and sometimes severe retinal ischemia, but still lacks neovascularization.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Birdshot Choroidopathy</strong> - Typically presents with distinctive yellow-white lesions in the retina, which are not apparent in the provided angiography images. This condition is an inflammatory process, not related to neovascularization seen in diabetic retinopathy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Proliferative diabetic retinopathy is the advanced stage of diabetic eye disease, marked by neovascularization, which requires aggressive treatment like laser photocoagulation to prevent severe visual loss. It is crucial for diabetics, particularly those with a long history or poorly controlled diabetes, to undergo regular eye examinations for early detection and management of diabetic retinopathy.</span></p>",
      "correct_choice_id": 52349,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 33227,
      "choices": [
        {
          "id": 132754,
          "text": "<p><span style=\"font-size:12.0pt;\">Fluorescein dye - visualised under cobalt blue filter</span></p>"
        },
        {
          "id": 132755,
          "text": "<p><span style=\"font-size:12.0pt;\">Lissamine dye - green filter</span></p>"
        },
        {
          "id": 132756,
          "text": "<p><span style=\"font-size:12.0pt;\">Lissamine dye cobalt blue filter</span></p>"
        },
        {
          "id": 132757,
          "text": "<p><span style=\"font-size:12.0pt;\">Fluorescein dye - visualised under green filter</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is the dye and filter used as seen in the image?&nbsp; (NEET PG 2018)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/15/screenshot-2024-01-15-111605.jpg\" alt=\"\" width=\"300\" height=\"188\"></span></p>",
      "unique_key": "Q1621468",
      "question_audio": null,
      "question_video": null,
      "map_id": 13399310,
      "difficulty_level": "beginner",
      "subjects_id": [
        8
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A. Fluorescein dye - visualised under cobalt blue filter</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">he most likely correct combination for fluorescein dye visualization is<strong> Fluorescein dye - visualized under cobalt blue filter</strong>. Fluorescein is a yellow dye that, when applied to the eye, emits a bright green fluorescence when illuminated with blue light from a cobalt blue filter. It's commonly used in ophthalmology to detect corneal abrasions, ulcers, or foreign bodies and to assess contact lens fit.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Lissamine Green dye - visualized under a green filter</strong>: Lissamine Green is a dye that stains devitalized cells and mucous filaments and is used to visualize damage to the conjunctiva and cornea, particularly in dry eye syndrome. It is typically observed under white light, not a green filter, so this combination is not standard.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Lissamine Green dye - visualized under a cobalt blue filter</strong>: This is not the standard practice for visualizing Lissamine Green dye. This dye is usually observed under white light, as the cobalt blue filter is specifically used to excite fluorescence from fluorescein dye.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Fluorescein dye - visualized under a green filter</strong>: Fluorescein dye is usually visualized under a blue light, not a green filter. When fluorescein is viewed under a green filter, the fluorescence is typically not visible because the green filter would block the green fluorescence emitted by the fluorescein dye.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective</strong>:&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In ophthalmology, different dyes and filters are used to aid in the diagnosis of various conditions. Fluorescein dye is visualized using a cobalt blue filter, which causes it to fluoresce and highlights areas of corneal compromise. It is crucial to use the appropriate filter for each dye to accurately diagnose and assess ocular surface disorders.</span></p>",
      "correct_choice_id": 132754,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased",
        "InvestigationBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 51496,
      "choices": [
        {
          "id": 205501,
          "text": "<p><span style=\"font-size:12.0pt;\">Herpes Simplex Virus type 2&nbsp;</span><span style=\"font-size:11.0pt;\">(</span><span style=\"font-size:12.0pt;\">HSV2)</span></p>"
        },
        {
          "id": 205502,
          "text": "<p><span style=\"font-size:12.0pt;\">Enterovirus 70</span></p>"
        },
        {
          "id": 205503,
          "text": "<p><span style=\"font-size:12.0pt;\">Human Papillomavirus (HPV)</span></p>"
        },
        {
          "id": 205504,
          "text": "<p><span style=\"font-size:12.0pt;\">Varicella-Zoster Virus</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Mother had painful vesicular lesions over genitalia one year back. Baby is born with features of meningitis and fever and rashes in abdomen and forearm and died within a week. Scrapings from lesions showed multinucleate giant cells. What is the most likely organism?&nbsp;</span>(INICET MAY 2024)</p>",
      "unique_key": "Q5596655",
      "question_audio": null,
      "question_video": null,
      "map_id": 13399311,
      "difficulty_level": "beginner",
      "subjects_id": [
        18
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Herpes Simplex Virus type 2 (HSV2)</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The correct answer is HSV2 (Herpes Simplex Virus Type 2). The clinical history provided in the question strongly suggests neonatal herpes infection.</span></li><li><span style=\"font-size:12.0pt;\">The mother had a history of painful vesicular lesions over the genitalia, which is characteristic of genital herpes caused by HSV2.</span></li><li><span style=\"font-size:12.0pt;\">Neonatal herpes can be transmitted from the mother to the baby during childbirth if the mother has an active HSV infection.</span></li><li><span style=\"font-size:12.0pt;\">The baby presented with symptoms of meningitis, fever, and rash, which are typical manifestations of neonatal herpes.</span></li><li><span style=\"font-size:12.0pt;\">The presence of multinucleated giant cells on scrapings from lesions further supports the diagnosis, as these are characteristic findings in herpes infections.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Enterovirus 70:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Enterovirus 70 is associated with acute hemorrhagic conjunctivitis, not with vesicular lesions or the neonatal symptoms described in the question.</span></li><li><span style=\"font-size:12.0pt;\">It does not typically cause multinucleated giant cells in lesions.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Human Papillomavirus (HPV)</strong>:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">HPV causes warts and is associated with genital warts, but it does not cause painful vesicular lesions or neonatal meningitis.</span></li><li><span style=\"font-size:12.0pt;\">HPV also does not produce multinucleated giant cells on lesion scrapings.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. VZV:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Varicella-Zoster Virus (VZV) can cause vesicular lesions, but the clinical scenario described (painful genital lesions in the mother) and the findings in the neonate (multinucleated giant cells and severe systemic symptoms) are more consistent with HSV2 rather than VZV.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Herpes Simplex Virus Type 2 (HSV2) is the most likely organism causing neonatal herpes, characterized by the presence of painful vesicular lesions in the mother and severe systemic symptoms including meningitis, fever, and rash in the newborn, along with multinucleated giant cells found in lesion scrapings.</span></li></ul>",
      "correct_choice_id": 205501,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13020,
      "choices": [
        {
          "id": 52042,
          "text": "<p><span style=\"font-size:12.0pt;\">Adenoid cystic carcinoma</span></p>"
        },
        {
          "id": 52043,
          "text": "<p><span style=\"font-size:12.0pt;\">Pleomorphic adenoma</span></p>"
        },
        {
          "id": 52044,
          "text": "<p><span style=\"font-size:12.0pt;\">Mucoepidermoid carcinoma</span></p>"
        },
        {
          "id": 52045,
          "text": "<p><span style=\"font-size:12.0pt;\">Malignant mixed tumor</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which is the most common lacrimal gland tumor? (</span>AIIMS May 2017)</p>",
      "unique_key": "Q7870261",
      "question_audio": null,
      "question_video": null,
      "map_id": 13399312,
      "difficulty_level": "beginner",
      "subjects_id": [
        8
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Pleomorphic adenoma</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Pleomorphic adenoma is the most common lacrimal gland tumor.</span></li><li><span style=\"font-size:12.0pt;\">It is also the most common epithelial tumor of the lacrimal gland.</span></li><li><span style=\"font-size:12.0pt;\">The most common epithelial tumors, in order of frequency, are as follows:</span><ol style=\"list-style-type:decimal;\"><li><span style=\"font-size:12.0pt;\">Benign mixed tumor (BMT), also known as a pleomorphic adenoma (PA)</span></li><li><span style=\"font-size:12.0pt;\">Adenoid cystic carcinoma (ACC)</span></li><li><span style=\"font-size:12.0pt;\">Pleomorphic adenocarcinoma (ACA)</span></li><li><span style=\"font-size:12.0pt;\">Mucoepidermoid carcinoma</span></li></ol></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Note: Most common malignant epithelial tumor of the lacrimal gland: Adenoid cystic carcinoma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Adenoid cystic carcinoma:</strong> Adenoid cystic carcinoma is a malignant tumor that can occur in various glands in the body, including the lacrimal gland. It is characterized by slow growth and the tendency to invade nearby structures.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Mucoepidermoid carcinoma</strong>: Mucoepidermoid carcinoma is another type of malignant tumor that can affect the lacrimal gland. It is characterized by a combination of mucin-secreting and squamous (epidermoid) cells.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Malignant mixed tumor</strong>: Malignant mixed tumor, also known as carcinoma ex pleomorphic adenoma, occurs when a previously benign pleomorphic adenoma transforms into a malignant tumor. It is less common than pleomorphic adenoma but represents a more aggressive form of lacrimal gland tumor.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Pleomorphic adenoma is the most common lacrimal gland tumor. It is usually benign and arises from the glandular tissue. It can sometimes have a mixture of cell types, hence the name \"pleomorphic.\"</span></p>",
      "correct_choice_id": 52043,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14020,
      "choices": [
        {
          "id": 56041,
          "text": "<p><span style=\"font-size:12.0pt;\">Focal laser photocoagulation</span></p>"
        },
        {
          "id": 56042,
          "text": "<p><span style=\"font-size:12.0pt;\">Pan-retinal photocoagulation</span></p>"
        },
        {
          "id": 56043,
          "text": "<p><span style=\"font-size:12.0pt;\">Grid laser photocoagulation</span></p>"
        },
        {
          "id": 56044,
          "text": "<p><span style=\"font-size:12.0pt;\">Scleral buckling</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A diabetic patient presented to you with visual acuity of 6/9 in one eye. Further investigations revealed pre-retinal hemorrhages with neovascularization at the optic disc. What is the next step in management?&nbsp;</span>(NEET PG 2022)</p>",
      "unique_key": "Q9883281",
      "question_audio": null,
      "question_video": null,
      "map_id": 13399313,
      "difficulty_level": "beginner",
      "subjects_id": [
        8
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. Pan-retinal photocoagulation</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The clinical vignette is suggestive of proliferative diabetic retinopathy with high-risk characteristics and the next step in management is pan-retinal photocoagulation.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Indications for PRP are:</strong></span></li></ul><ol><li><span style=\"font-size:12.0pt;\">Proliferative Diabetic Retinopathy with high-risk characteristics</span></li><li><span style=\"font-size:12.0pt;\">Neovascularization of iris (NVI)</span></li><li><span style=\"font-size:12.0pt;\">Severe NPDR associated with:</span><ul><li><span style=\"font-size:12.0pt;\">Poor compliance for follow up</span></li><li><span style=\"font-size:12.0pt;\">Before cataract surgery/YAG capsulotomy</span></li><li><span style=\"font-size:12.0pt;\">Renal failure</span></li><li><span style=\"font-size:12.0pt;\">One-eyed patient</span></li><li><span style=\"font-size:12.0pt;\">Pregnancy</span></li></ul></li></ol><ul><li><span style=\"font-size:12.0pt;\">It is done using Yellow – Green spectrum laser - double frequency Nd YAG (532) laser or argon or diode laser.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/03/untitled-167.jpg\" alt=\"\" width=\"300\" height=\"215\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Diabetic retinopathy is used to describe retinal changes seen in diabetic patients. It is classified into the following types:</span></p><ul><li><span style=\"font-size:12.0pt;\">Non-proliferative diabetic retinopathy (NPDR)</span></li><li><span style=\"font-size:12.0pt;\">Proliferative diabetic retinopathy (PDR)</span></li><li><span style=\"font-size:12.0pt;\">Diabetic maculopathy</span></li><li><span style=\"font-size:12.0pt;\">Advanced diabetic eye disease</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/09/abbreviated-early-treatment-diabetic-retinopathy-study_page_1.jpg\" alt=\"\" width=\"1000\" height=\"1342\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Focal laser photocoagulation:&nbsp;</strong>Focal laser photocoagulation is used to treat specific areas of retinal edema, particularly in cases of diabetic maculopathy. It is not the first choice for treating PDR with high-risk characteristics.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Grid laser photocoagulation:&nbsp;</strong>Grid laser photocoagulation is also used to treat diffuse macular edema by applying laser burns in a grid pattern. It is not indicated for the treatment of PDR with neovascularization.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Scleral buckling:&nbsp;</strong>Scleral buckling is a surgical procedure used to repair retinal detachment. It is not appropriate for treating PDR with neovascularization and pre-retinal hemorrhages.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Pan-retinal photocoagulation (PRP) is the recommended management for proliferative diabetic retinopathy with high-risk characteristics such as neovascularization at the optic disc and pre-retinal hemorrhages.</span></p>",
      "correct_choice_id": 56042,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 24671,
      "choices": [
        {
          "id": 98645,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 3</span></p>"
        },
        {
          "id": 98646,
          "text": "<p><span style=\"font-size:12.0pt;\">2, 4</span></p>"
        },
        {
          "id": 98647,
          "text": "<p><span style=\"font-size:12.0pt;\">4</span></p>"
        },
        {
          "id": 98648,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 2, 3</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of these options are considered direct gonioscopes?(</span>INICET May 2023)</p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Goldmann</span></li><li><span style=\"font-size:12.0pt;\">Richardson</span></li><li><span style=\"font-size:12.0pt;\">Zeis</span></li><li><span style=\"font-size:12.0pt;\">Koeppe</span></li></ol>",
      "unique_key": "Q9065366",
      "question_audio": null,
      "question_video": null,
      "map_id": 13399314,
      "difficulty_level": "intermediate",
      "subjects_id": [
        8
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) 2, 4</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Richardson and Koeppe are direct gonioscopes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>DIRECT GONIOSCOPY</strong> - It is performed with a steep convex lens which permits light from the angle to exit the eye closer to the perpendicular at the lens - air interface. These lenses are used with an operating microscope.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">DIRECT GONIOSCOPE IMAGE</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/11/inicet-may-2023-optha-1-1.jpg\" alt=\"\" width=\"500\" height=\"311\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Examples –</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Koeppe goniolens</span></li><li><span style=\"font-size:12.0pt;\">Richardson- Shaffer's lens</span></li><li><span style=\"font-size:12.0pt;\">Sieback goniolens</span></li><li><span style=\"font-size:12.0pt;\">Worth goniolens</span></li><li><span style=\"font-size:12.0pt;\">Swan Jacob's lens</span></li><li><span style=\"font-size:12.0pt;\">Huskins barkan's lens</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>INDIRECT GONIOSCOPY</strong> - uses mirrors or prism to overcome the problem of total internal reflection. Moreover, it uses the slit lamp's illumination and magnification system to its advantage.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">INDIRECT GONIOSCOPE IMAGE</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/11/inicet-may-2023-optha-1-2.jpg\" alt=\"\" width=\"700\" height=\"423\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Examples –</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Goldmann Gonioprism</span></li><li><span style=\"font-size:12.0pt;\">Zeis Gonioprism</span></li><li><span style=\"font-size:12.0pt;\">Tokel Gonioprism</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Direct gonioscopes like Richardson and Koeppe provide a detailed and direct view of the anterior chamber angle, which is valuable in diagnostic and certain therapeutic procedures.</span></p>",
      "correct_choice_id": 98646,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET",
        "InstrumentsBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 60492,
      "choices": [
        {
          "id": 241261,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Lambert-Eaton Myasthenic Syndrome</span></span></span></p>"
        },
        {
          "id": 241262,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Botulism</span></span></span></p>"
        },
        {
          "id": 241263,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Myasthenia Gravis</span></span></span></p>"
        },
        {
          "id": 241264,
          "text": "<p><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Multiple Sclerosis</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">A 52-year-old man presents to his primary care physician with complaints of double vision, drooping of his right eyelid, and difficulty swallowing, especially in the evening hours. He mentions that his symptoms are mild in the morning but worsen throughout the day, making it hard for him to keep his eyes open and causing slurred speech by late afternoon. He denies any history of trauma, recent infections, or significant changes in his medications. His medical history includes hypertension, managed with lifestyle modifications. During the examination, the physician notices right-sided ptosis and weakness in the extraocular muscles without any sensory loss or abnormal pupillary reflexes. The physician decides to administer a short-acting medication intravenously to assess the response, and within minutes, the patient&rsquo;s symptoms improve significantly, with resolution of ptosis and improved speech clarity. Which of the following is the most likely diagnosis?</span></span></span></p>",
      "unique_key": "Q7820497",
      "question_audio": null,
      "question_video": null,
      "map_id": 13399315,
      "difficulty_level": "beginner",
      "subjects_id": [
        8
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Correct Answer: </span></strong><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">C. Myasthenia Gravis</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Myasthenia Gravis (MG) is an autoimmune disorder characterized by fluctuating muscle weakness due to the destruction of acetylcholine receptors at the neuromuscular junction by autoantibodies. Patients typically present with symptoms that worsen with activity and improve with rest, such as ptosis, diplopia, and bulbar symptoms including dysphagia and slurred speech. In this patient&rsquo;s case, the classic pattern of worsening symptoms throughout the day and improvement after rest is highly suggestive of MG. The dramatic response to anticholinesterase medications, like edrophonium, confirms the diagnosis by temporarily increasing acetylcholine at the neuromuscular junction, which improves muscle strength. Additional tests, including the ice pack test and acetylcholine receptor antibody testing, can further support the diagnosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option</span></strong> <strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">A. Lambert-Eaton Myasthenic Syndrome:</span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"> This condition is associated with antibodies against presynaptic calcium channels, leading to impaired acetylcholine release. Symptoms often include proximal muscle weakness that improves with activity, unlike MG, and it does not show significant improvement with anticholinesterase medications.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option</span></strong> <strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">B. Botulism:</span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"> Botulism results from a neurotoxin that inhibits acetylcholine release at the neuromuscular junction, causing descending paralysis, ptosis, and dysphagia. However, it typically progresses more rapidly and does not respond to anticholinesterase medications. Autonomic features such as fixed, dilated pupils are also characteristic but are not present in this case.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option</span></strong> <strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">D. Multiple Sclerosis:</span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"> Multiple Sclerosis is a central nervous system demyelinating disorder presenting with varied neurological symptoms such as optic neuritis, motor deficits, and sensory changes. Ocular symptoms in MS are not characterized by fluctuating muscle weakness that improves with anticholinesterase medications, distinguishing it from MG.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Myasthenia Gravis is marked by fluctuating muscle weakness that worsens with exertion and improves with rest, particularly affecting ocular and bulbar muscles. Diagnosis is confirmed by clinical presentation, response to anticholinesterase medications, and tests such as acetylcholine receptor antibodies and Single Fiber Electromyography.</span></span></span></p>",
      "correct_choice_id": 241263,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13034,
      "choices": [
        {
          "id": 52098,
          "text": "<p><span style=\"font-size:12.0pt;\">Presbyopia</span></p>"
        },
        {
          "id": 52099,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿Aphakia</span></p>"
        },
        {
          "id": 52100,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿Pediatric pseudophakia</span></p>"
        },
        {
          "id": 52101,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿Hypermetropia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The spectacles shown in the image are not used for the management of which of the following? (</span>AIIMS May 2018)</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/29/picture5_flbmEsJ.jpg\" alt=\"\" width=\"400\" height=\"142\"></span></p>",
      "unique_key": "Q5811287",
      "question_audio": null,
      "question_video": null,
      "map_id": 13400426,
      "difficulty_level": "intermediate",
      "subjects_id": [
        8
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Hypermetropia</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The image shows a bifocal spectacle that is made of lenses with two different optical powers (upper half for distant vision and lower half for near vision). Hypermetropia, or farsightedness, primarily affects near vision, necessitating correction that provides a uniform optical adjustment across the entire lens surface to assist with close vision tasks, rather than segmented correction like in bifocals.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Bifocal spectacles are typically used for treating following conditions:</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/04/screenshot-2024-07-04-152331.png\" alt=\"\" width=\"1000\" height=\"234\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Bifocal spectacles are not typically used for treating hypermetropia, which generally requires a uniform optical correction across the entire lens to aid in near tasks. Bifocals are instead beneficial in conditions requiring simultaneous correction for near and far vision, such as presbyopia, or specific needs following surgical interventions like in aphakia and pediatric pseudophakia.</span></p>",
      "correct_choice_id": 52101,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "DiagnosisBased",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 48990,
      "choices": [
        {
          "id": 195535,
          "text": "<p><span style=\"font-size:12.0pt;\">Proptosis</span></p>"
        },
        {
          "id": 195536,
          "text": "<p><span style=\"font-size:12.0pt;\">Squint</span></p>"
        },
        {
          "id": 195537,
          "text": "<p><span style=\"font-size:12.0pt;\">Ptosis</span></p>"
        },
        {
          "id": 195538,
          "text": "<p><span style=\"font-size:12.0pt;\">Diplopia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">Following instrument is used to measure:&nbsp;(INICET Nov 2023)</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/12/screenshot-2024-06-12-175831.JPG\" alt=\"\" width=\"300\" height=\"138\"></span></p>",
      "unique_key": "Q2011738",
      "question_audio": null,
      "question_video": null,
      "map_id": 13400427,
      "difficulty_level": "beginner",
      "subjects_id": [
        8
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Proptosis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The image shows a Hertel exophthalmometer, which is specifically designed to measure proptosis—the forward displacement of the eye.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This instrument directly measures how much the eyeball protrudes forward from the eye socket. It is essential in diagnosing conditions like thyroid eye disease where proptosis is a common feature.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Design and Use</strong>: It consists of a ruler and two lateral mirrors or prisms that align with the lateral orbital rim, allowing for accurate measurement of the anterior position of the cornea relative to the lateral orbital wall.</span><ol style=\"list-style-type:decimal;\"><li><span style=\"font-size:12.0pt;\"><strong>Bilateral Assessment</strong>: The Hertel exophthalmometer can measure the protrusion of both eyes simultaneously, allowing for comparison between the two. This is vital for identifying asymmetrical proptosis, which can be an indicator of more serious unilateral orbital disease.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Quantitative Data</strong>: It provides quantitative data that can help in monitoring the progression or resolution of orbital diseases over time. This is particularly useful in tracking the effectiveness of treatment for conditions that cause proptosis.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Simple and Non-invasive</strong>: The device is straightforward to use and non-invasive, making it a patient-friendly tool for regular follow-up assessments in clinical settings.</span></li></ol></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The Hertel exophthalmometer is a specialized tool for assessing the extent of proptosis in conditions affecting the orbit and surrounding tissues, helping guide further diagnostic and therapeutic steps for conditions like thyroid eye disease.</span></p>",
      "correct_choice_id": 195535,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased",
        "INICET",
        "InstrumentsBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13059,
      "choices": [
        {
          "id": 52198,
          "text": "<p><span style=\"font-size:12.0pt;\">Nasolacrimal duct syringing</span></p>"
        },
        {
          "id": 52199,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿Anterior ethmoidal nerve block</span></p>"
        },
        {
          "id": 52200,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿Infraorbital nerve block</span></p>"
        },
        {
          "id": 52201,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿Trephination of frontal sinus</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following procedure is shown in the image given below? (</span>INICET May 2020)</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/29/picture1_wIiIfVz.jpg\" alt=\"\" width=\"250\" height=\"334\"></span></p>",
      "unique_key": "Q6174102",
      "question_audio": null,
      "question_video": null,
      "map_id": 13400428,
      "difficulty_level": "beginner",
      "subjects_id": [
        8
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Anterior ethmoidal nerve block</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The procedure shown in the given image is an anterior ethmoidal nerve block.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The anterior ethmoidal nerve supplies the roof of the nasal cavity. It is a branch of the Nasociliary nerve which in turn is a branch of the ophthalmic nerve (V1). It is sometimes used in endonasal surgery.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Detailing the Procedure:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Purpose:</strong> Used predominantly to numb the area for surgical procedures within the nasal cavity.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Method:</strong> Involves injection near the anterior ethmoidal foramen to block the nerve that transmits sensation from the nasal roof.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Nasolacrimal duct syringing:</strong> This procedure is used to check the patency of the nasolacrimal duct. It involves flushing the duct with saline to check for blockages, typically conducted by inserting a syringe into the puncta near the medial canthus of the eye. However, this is not related to the procedure shown in the image since it involves the eye directly and is performed with the eyes open to access the puncta.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Infraorbital nerve block:</strong> This block anesthetizes the area supplied by the infraorbital nerve, which affects the lower eyelid, upper lip, and cheek. It is generally performed via an intraoral approach at the infraorbital foramen, located below the orbit, which is not depicted in the image.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Trephination of the frontal sinus:</strong> This surgical procedure involves making an incision in the floor of the frontal sinus to facilitate drainage. This procedure targets a different anatomic location and involves surgical tools, not the approach shown in the image.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">An anterior ethmoidal nerve block is crucial for numbing the nasal cavity area, particularly in endonasal surgeries. It is essential for procedures requiring detailed work near the roof of the nasal cavity, reflecting the significance of understanding the specific nerve anatomy for effective anesthesia.</span></p>",
      "correct_choice_id": 52199,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ImageBased",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13910,
      "choices": [
        {
          "id": 55601,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Retinal pigmentation</span></span></span></p>"
        },
        {
          "id": 55602,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Pale waxy disc</span></span></span></p>"
        },
        {
          "id": 55603,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Narrowing of vessels</span></span></span></p>"
        },
        {
          "id": 55604,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">ERG &ndash; normal</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">What among the following is not true about retinitis pigmentosa? (</span></span>NEET PG 2019)</p>",
      "unique_key": "Q2222228",
      "question_audio": null,
      "question_video": null,
      "map_id": 13400429,
      "difficulty_level": "beginner",
      "subjects_id": [
        8
      ],
      "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. D. ERG &ndash; normal</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">ERG is abnormal in retinitis pigmentosa.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Retinitis pigmentosa is a primary <strong>pigmentary</strong> <strong>retinal</strong> <strong>dystrophy</strong> predominantly affecting the <strong>rods</strong> more than the cones.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">It is the most common hereditary fundus dystrophy, with the most common mode of inheritance being <strong>autosomal</strong> <strong>recessive</strong>.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">In early disease, it shows reduced scotopic rod and combined responses, and photopic responses reduce with progression.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Eventually, the ERG becomes extinguished.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The characteristic visual symptom is <strong>night</strong> <strong>blindness</strong>, which may present several years before visible changes in the retina appear.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Dark adaptation is affected, and tubular vision may occur in advanced cases.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Fundus changes include bone-spicule retinal pigmentation, arteriolar attenuation, and &#39;waxy&#39; disc pallor.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/03/untitled-119.jpg\" style=\"height:244px; width:300px\" /></span></span></span></p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Visual field changes</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">- </span></span></span>\r\n\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Annular or ring-shaped scotoma is a typical feature which corresponds to the degenerated equatorial zone of retina. As the disease progresses, scotoma increases anteriorly and posteriorly and ultimately only central vision is left (tubular vision). Eventually even this is also lost and the patient becomes blind.</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Electrophysiological changes</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">- </span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"margin-left:40px; text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">1. Electro-retinogram (ERG) is subnormal or abolished.</span></span></span></p>\r\n\r\n<p style=\"margin-left:40px; text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">2. Electro-oculogram (EOG) shows absence of light peak.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Pale Waxy Disc:</span></strong><span style=\"font-size:12.0pt\"> Optic disc pallor due to progressive degeneration.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Narrowing of Vessels:</span></strong><span style=\"font-size:12.0pt\"> Attenuation of retinal arterioles due to retinal thinning and atrophy.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. </span></strong><span style=\"font-size:12.0pt\">&nbsp;<strong>ERG (Electroretinogram:</strong> ERG is not normal in retinitis pigmentosa. It shows abnormal findings, such as:</span></span></span></p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Early Disease:</span></strong><span style=\"font-size:12.0pt\"> Reduced scotopic (rod) response and combined responses.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Progression:</span></strong><span style=\"font-size:12.0pt\"> Reduced photopic (cone) responses.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Advanced Disease:</span></strong><span style=\"font-size:12.0pt\"> ERG becomes extinguished or abolished</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">In retinitis pigmentosa, the ERG is not normal; it shows progressive abnormalities reflecting the degeneration of photoreceptor cells. Other features include retinal pigmentation, pale waxy disc, and narrowing of retinal vessels.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>",
      "correct_choice_id": 55604,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "InvestigationBased",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 60493,
      "choices": [
        {
          "id": 241265,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">0.5-1 kg</span></span></span></p>"
        },
        {
          "id": 241266,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">1.5-2.5 kg</span></span></span></p>"
        },
        {
          "id": 241267,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">5-7 kg.</span></span></span></p>"
        },
        {
          "id": 241268,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">10-12 kg</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">What is the typical weight range of rabbits used in ophthalmological research? (AIIMS NOV 2016)</span></span></span></p>",
      "unique_key": "Q8454442",
      "question_audio": null,
      "question_video": null,
      "map_id": 13400430,
      "difficulty_level": "intermediate",
      "subjects_id": [
        8
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Correct Answer: B. 1.5-2.5 kg</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Rabbits used in ophthalmological experiments generally weigh between 1.5 to 2.5 kg. This weight range is ideal for handling and conducting precise ophthalmological studies.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/09/screenshot-2024-10-05-183945.jpg\" style=\"height:260px; width:500px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. 0.5-1 kg</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> - This weight range is too low for typical ophthalmological research involving rabbits.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. 5-7 kg</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> - This weight range is too high and not common for ophthalmological studies using rabbits.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. 10-12 kg</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> - This weight range is also too high and not suitable for standard ophthalmological experiments.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The typical weight range for rabbits used in ophthalmological research is 1.5-2.5 kg, making them suitable for handling and detailed eye studies.</span></span></span></p>",
      "correct_choice_id": 241266,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13078,
      "choices": [
        {
          "id": 52274,
          "text": "<p><span style=\"font-size:12.0pt;\">Posterior staphyloma</span></p>"
        },
        {
          "id": 52275,
          "text": "<p><span style=\"font-size:12.0pt;\">Fundal coloboma</span></p>"
        },
        {
          "id": 52276,
          "text": "<p><span style=\"font-size:12.0pt;\">Congenital rubella</span></p>"
        },
        {
          "id": 52277,
          "text": "<p><span style=\"font-size:12.0pt;\">Toxoplasmosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">In which of the following conditions do you see punched-out lesions of the retina? (</span>INICET May 2022)</p>",
      "unique_key": "Q3090688",
      "question_audio": null,
      "question_video": null,
      "map_id": 13400501,
      "difficulty_level": "intermediate",
      "subjects_id": [
        8
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>D) Toxoplasmosis</strong></span></p><p><span style=\"font-size:10.5pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\">Toxoplasmosis is a parasitic infection caused by Toxoplasma gondii that affects the central nervous system and retina in humans.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">It can occur as 3 forms:</span></p><p>&nbsp;</p><ol style=\"list-style-type:lower-roman;\"><li><span style=\"font-size:12.0pt;\"><strong>Congenital</strong>: infants are typically born with inactive disease, and doctors may observe healed punched-out chorioretinal lesions in the macular region.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Acquired</strong>: can also result in similar punched-out lesions, along with punctate outer retinal toxoplasmosis.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Recurrent Toxoplasmosis:</strong> Patients may experience multiple episodes of retinal inflammation, leading to further accumulation of these punched-out lesions over time.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Posterior staphyloma:</strong> This refers to an outpouching or deformation of the posterior shell of the eye, often associated with severe myopia but not characterized by punched-out lesions.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Fundal coloboma:</strong> A congenital malformation resulting in missing pieces of tissue in structures forming the eye, such as the choroid and retina, which does not typically present as punched-out lesions.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Congenital rubella:</strong> While it can cause retinal changes, the signature features often include salt and pepper retinopathy rather than punched-out lesions.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The appearance of punched-out lesions in the retina is crucial for diagnosing toxoplasmosis. This understanding can aid in distinguishing toxoplasmosis from other infectious or congenital conditions that affect the retina, guiding appropriate diagnostic and therapeutic interventions.</span></p>",
      "correct_choice_id": 52277,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13106,
      "choices": [
        {
          "id": 52386,
          "text": "<p><span style=\"font-size:12.0pt;\">Fincham's test</span></p>"
        },
        {
          "id": 52387,
          "text": "<p><span style=\"font-size:12.0pt;\">Corneal tattooing</span></p>"
        },
        {
          "id": 52388,
          "text": "<p><span style=\"font-size:12.0pt;\">Optical Iridectomy</span></p>"
        },
        {
          "id": 52389,
          "text": "<p><span style=\"font-size:12.0pt;\">To find out the axis in astigmatism</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">You can use a stenopaeic slit for all of the following except? (</span>AIIMS Nov 2018)</p>",
      "unique_key": "Q2277939",
      "question_audio": null,
      "question_video": null,
      "map_id": 13400502,
      "difficulty_level": "intermediate",
      "subjects_id": [
        8
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Corneal tattooing</strong></span></p><p><span style=\"font-size:10.5pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\">Stenopaeic slit is not used in corneal tattooing.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Corneal tattooing was introduced as an attempt to mask the leukomatous opacities of the eye during ancient times. Corneal tattooing is also found to reduce glare within the eye due to iris loss and increase visual acuity.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Many different types of inks are used throughout history and today for the dyeing of the cornea. Today, India ink is the most commonly used, providing safe and long-lasting effects,&nbsp;but other dyes include metallic colors in powder form, various organic dyes, and uveal pigment from animal eyes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Fincham's test:</strong> Used specifically to evaluate differences in the nature of halos seen by patients, aiding in the differential diagnosis between cataract and glaucoma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Optical Iridectomy:</strong> The stenopaeic slit assists in locating the best area on the cornea for performing an iridectomy, essential in cases where peripheral vision needs to be preserved.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. To find out the axis in astigmatism:</strong> It is instrumental in determining the precise axis for corrective lenses, which is vital for proper astigmatism management.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>STENOPAEIC SLIT</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/29/picture2_dRKMWwS.jpg\" alt=\"\" width=\"300\" height=\"266\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Uses of stenopaeic slit test:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Fincham's test: to differentiate between the colored halos due to cataract and corneal edema due to glaucoma.</span></li><li><span style=\"font-size:12.0pt;\">To find out the optimal site for optical iridectomy in case of corneal opacities.</span></li><li><span style=\"font-size:12.0pt;\">To find out the axis in astigmatism.</span></li></ul>",
      "correct_choice_id": 52387,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13149,
      "choices": [
        {
          "id": 52557,
          "text": "<p><span style=\"font-size:12.0pt;\">15 minutes of arc</span></p>"
        },
        {
          "id": 52558,
          "text": "<p><span style=\"font-size:12.0pt;\">5 minutes of arc</span></p>"
        },
        {
          "id": 52559,
          "text": "<p><span style=\"font-size:12.0pt;\">10 minutes of arc</span></p>"
        },
        {
          "id": 52560,
          "text": "<p><span style=\"font-size:12.0pt;\">20 minute of arc</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient has presented for a routine eye evaluation. You have checked his visual acuity using Snellen's chart and found it to be 6/6. What is the minimum angle of resolution? (</span>INICET Nov 2022)</p>",
      "unique_key": "Q1212583",
      "question_audio": null,
      "question_video": null,
      "map_id": 13400503,
      "difficulty_level": "beginner",
      "subjects_id": [
        8
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) 5 minutes of arc</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The angle subtended for a patient with 6/6 vision is 5 minutes of arc.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Visual acuity is a measure of the spatial resolution of the eye or an estimation of its ability to discriminate between two points.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Snellen's chart consists of a series of letters arranged in lines, each diminishing in size. Each whole letter will subtend the angle of 5 minutes at the nodal point of the eye at the given distance.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/29/picture6_JFtDR2I.jpg\" alt=\"\" width=\"500\" height=\"310\"></span></p><p>&nbsp;</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The minimum angle of resolution for someone with a visual acuity of 6/6 using a Snellen chart is 5 minutes of arc. This indicates the precise and detailed visual capability required to resolve fine details at a standard distance, a fundamental concept in understanding and assessing visual acuity in clinical settings.</span></p>",
      "correct_choice_id": 52558,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13993,
      "choices": [
        {
          "id": 55933,
          "text": "<p><span style=\"font-size:12.0pt;\">Soft exudate, Hypertension﻿﻿﻿</span></p>"
        },
        {
          "id": 55934,
          "text": "<p><span style=\"font-size:12.0pt;\">Hard exudate, Diabetes mellitus</span></p>"
        },
        {
          "id": 55935,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿﻿﻿﻿Flame-shaped hemorrhages, Hypertension</span></p>"
        },
        {
          "id": 55936,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿Soft exudate, Central retinal vein occlusion</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 60-year-old patient with progressive painless loss of vision presents to the ophthalmology OPD. Fundus picture of the patient is given below. What could be the probable finding and the cause of it? (</span>NEET PG 2021)</p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/03/untitled-149.jpg\" alt=\"\" width=\"300\" height=\"149\"></span></p>",
      "unique_key": "Q3458326",
      "question_audio": null,
      "question_video": null,
      "map_id": 13400504,
      "difficulty_level": "beginner",
      "subjects_id": [
        8
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. Hard exudate, Diabetes mellitus</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The given image shows small, discrete yellowish, waxy areas with discrete margins that are suggestive of hard exudates, seen in diabetic macular edema.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/08/screenshot-2023-11-08-185030.png\" alt=\"\" width=\"1000\" height=\"716\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>COTTON WOOL SPOT vs HARD EXUDATE</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/08/picture533366.jpg\" alt=\"\" width=\"300\" height=\"105\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Diabetic retinopathy</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/08/picture6666.jpg\" alt=\"\" width=\"300\" height=\"228\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Hypertensive retinopathy</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/08/picture7222.jpg\" alt=\"\" width=\"300\" height=\"257\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Central retinal vein occlusion (CRVO)</strong> – Fundoscopy reveals massive engorgement, congestion, and tortuosity of retinal veins. Ischemic CRVO has massive retinal hemorrhages giving a splashed tomato appearance involving the whole fundus.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/08/picture83333.jpg\" alt=\"\" width=\"300\" height=\"260\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Soft exudate, Hypertension:&nbsp;</strong>Soft exudates, also known as cotton wool spots, are whitish fluffy spots with indistinct margins.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">They occur around infarcted areas and result from swelling of nerve fiber layer axons.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Associated with hypertensive retinopathy, toxaemic retinopathy of pregnancy, diabetic retinopathy, anemias, and collagen disorders like discoid lupus erythematosus, polyarteritis nodosa, and scleroderma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Flame-shaped hemorrhages, Hypertension:&nbsp;</strong>Flame-shaped hemorrhages are superficial retinal hemorrhages that occur due to disruption of the capillaries in the retinal nerve fiber layer.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">They are seen in diabetic retinopathy, non-ischemic central retinal vein occlusion, traumatic retinopathy, Eale's disease, hypertensive retinopathy, and anemic retinopathy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Soft exudate, Central retinal vein occlusion:&nbsp;</strong>Central retinal vein occlusion (CRVO) is characterized by massive engorgement, congestion, and tortuosity of retinal veins.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Ischemic CRVO has massive retinal hemorrhages giving a splashed tomato appearance involving the whole fundus.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Soft exudates can be seen in CRVO but are not the primary finding.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Hard exudates are characteristic findings in diabetic retinopathy, indicating chronic localized edema and composed of leaked lipoproteins and lipid-filled macrophages. They present as small, discrete yellowish, waxy areas with distinct margins in the retina.</span></p>",
      "correct_choice_id": 55934,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13070,
      "choices": [
        {
          "id": 52242,
          "text": "<p><span style=\"font-size:12.0pt;\">Left occipital lobe</span></p>"
        },
        {
          "id": 52243,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿Right occipital lobe</span></p>"
        },
        {
          "id": 52244,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿Left geniculate body</span></p>"
        },
        {
          "id": 52245,
          "text": "<p><span style=\"font-size:12.0pt;\">Optic chiasma</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Identify the site of the lesion: (</span>INICET May 2021)</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/29/picture13_6zdy8Mg.jpg\" alt=\"\" width=\"500\" height=\"261\"></span></p>",
      "unique_key": "Q4042651",
      "question_audio": null,
      "question_video": null,
      "map_id": 13400505,
      "difficulty_level": "intermediate",
      "subjects_id": [
        8
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Left occipital lobe</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The visual field defect is right homonymous hemianopia with macular-sparing.</span></li><li><span style=\"font-size:12.0pt;\">It is caused by lesions of the left occipital lobe, which is contralateral/crossing of fibers.</span></li><li><span style=\"font-size:12.0pt;\">Head injury is a common cause of such lesions.</span></li><li><span style=\"font-size:12.0pt;\">These lesions may be associated with visual hallucinations, denial of blindness (Anton syndrome), and the Riddoch phenomenon.</span></li><li><span style=\"font-size:12.0pt;\">These lesions are commonly due to occlusion of the posterior cerebral artery. The part of the occipital lobe representing the peripheral field vision is supplied by the posterior cerebral artery.</span></li><li><span style=\"font-size:12.0pt;\">The lesions generally spare the central vision/macular vision since the area at the tip of the calcarine cortex, representing the central macular vision, is supplied by a branch of the middle cerebral artery.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Right Occipital Lobe:</strong> This would cause a left-sided homonymous hemianopia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Left Geniculate Body:</strong> Lesions here typically produce similar visual field defects as occipital lobe lesions but may have different associated clinical signs and symptoms.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Optic Chiasma:</strong> Lesions at the optic chiasm typically produce bitemporal hemianopia, which is not demonstrated in the visual field tests provided.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/29/picture135.jpg\" alt=\"\" width=\"600\" height=\"499\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">A lesion in the left occipital lobe is the most likely cause of the right homonymous hemianopia with macular sparing shown in the visual field tests. This understanding is critical for accurately diagnosing the underlying condition, potentially a vascular event, and directing appropriate management and intervention strategies.</span></p>",
      "correct_choice_id": 52242,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13048,
      "choices": [
        {
          "id": 52154,
          "text": "<p><span style=\"font-size:12.0pt;\">Removal of the foreign body</span></p>"
        },
        {
          "id": 52155,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿Check for visual acuity</span></p>"
        },
        {
          "id": 52156,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿Give antibiotics</span></p>"
        },
        {
          "id": 52157,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿Do primary survey</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient presents to the emergency and his ocular examination reveals the following. Which of the following is not done initially? (</span>AIIMS May 2019)</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/29/picture4_ReZiWnL.jpg\" alt=\"\" width=\"300\" height=\"204\"></span></p>",
      "unique_key": "Q6652933",
      "question_audio": null,
      "question_video": null,
      "map_id": 13400506,
      "difficulty_level": "beginner",
      "subjects_id": [
        8
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Removal of the foreign body</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The image shows an eye with a metallic foreign body causing a penetrating injury. In such cases, immediate removal of the foreign body is not recommended as an initial step because doing so may exacerbate the injury or lead to complications such as infection or further mechanical damage to the eye structures.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Proper Initial Steps Include:</strong></span><br>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Check for visual acuity:</strong> This helps assess the extent of damage to the eye's visual function and provides a baseline for future comparisons.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Give antibiotics:</strong> Prophylactic treatment to prevent infection, especially considering the risk introduced by the foreign object.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Do primary survey:</strong> Ensures that the patient's overall health and other potential life-threatening conditions are addressed (part of the ABCDE approach - Airway, Breathing, Circulation, Disability, Exposure).</span><br><br>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Further Management:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>CT scan:</strong> To precisely locate the foreign body and any possible penetration into the orbital or cranial cavities, helping plan for surgical intervention.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Avoid MRI:</strong> Due to the risk of movement of the metallic object, which can cause more damage.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Surgical exploration and repair in the operating theatre:</strong> To safely remove the foreign body under controlled conditions, minimizing risk of further damage.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In cases of ocular injuries involving foreign bodies, immediate removal is not advised due to the potential for further damage. Initial steps should focus on assessment, stabilization, and prevention of infection, followed by careful planning and execution of the foreign body removal under appropriate surgical conditions.</span></p>",
      "correct_choice_id": 52154,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ImageBased",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 60494,
      "choices": [
        {
          "id": 241269,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Light-near dissociation</span></span></span></p>"
        },
        {
          "id": 241270,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Relative afferent pupillary defect</span></span></span></p>"
        },
        {
          "id": 241271,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Anisocoria</span></span></span></p>"
        },
        {
          "id": 241272,
          "text": "<p><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Horner&rsquo;s syndrome</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">A 62-year-old man with a history of hypertension and poorly controlled diabetes presents to his ophthalmologist with complaints of gradually worsening vision in both eyes over the past year. His intraocular pressure is found to be elevated, and fundoscopy reveals optic disc cupping with nerve fiber layer thinning. Based on this finding, which of the following pupillary abnormalities is most commonly associated with primary open-angle glaucoma?</span></span></span></p>",
      "unique_key": "Q5661517",
      "question_audio": null,
      "question_video": null,
      "map_id": 13400627,
      "difficulty_level": "intermediate",
      "subjects_id": [
        8
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Correct Answer: </span></strong><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">B. Relative afferent pupillary defect</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">A relative afferent pupillary defect (RAPD), also known as a Marcus Gunn pupil, is an important clinical sign in primary open-angle glaucoma, indicating asymmetric optic nerve damage. It occurs when the affected eye has a defect in the afferent pathway of the pupillary light reflex. During the swinging flashlight test, the pupil of the affected eye dilates slightly when the light is shone on it, instead of remaining constricted as it would in a normal response. This finding reflects early and often asymmetric optic nerve damage seen in glaucoma.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option</span></strong> <strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">A. Light-near dissociation</span></strong><br />\r\n<span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Light-near dissociation is characterized by pupils that do not constrict in response to light but do constrict during accommodation, commonly seen in conditions like Argyll Robertson pupil and Parinaud syndrome. It is not typically associated with glaucoma.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option</span></strong> <strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">C. Anisocoria</span></strong><br />\r\n<span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Anisocoria refers to unequal pupil sizes and can be physiological or related to various neurological conditions. It does not specifically indicate optic nerve damage or glaucoma.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option</span></strong> <strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">D. Horner&rsquo;s syndrome</span></strong><br />\r\n<span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Horner&rsquo;s syndrome is characterized by ptosis, miosis, and anhidrosis due to sympathetic pathway disruption. It does not involve the optic nerve or the afferent pathway and is unrelated to glaucoma.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">A relative afferent pupillary defect (RAPD) is a key clinical finding in primary open-angle glaucoma that signals asymmetric optic nerve damage. This condition is identified by the swinging flashlight test, which shows an abnormal pupillary response, reflecting the impact of glaucoma on the optic nerve pathways.</span></span></span></p>",
      "correct_choice_id": 241270,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13133,
      "choices": [
        {
          "id": 52494,
          "text": "<p><span style=\"font-size:12.0pt;\">Amitriptyline</span></p>"
        },
        {
          "id": 52495,
          "text": "<p><span style=\"font-size:12.0pt;\">Sertraline</span></p>"
        },
        {
          "id": 52496,
          "text": "<p><span style=\"font-size:12.0pt;\">Mirtazapine</span></p>"
        },
        {
          "id": 52497,
          "text": "<p><span style=\"font-size:12.0pt;\">Fluvoxamine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient who is a known case of angle-closure glaucoma has been diagnosed with major depressive disorder. Which of the following drugs have to be avoided in this patient? (</span>INICET Nov 2021)</p>",
      "unique_key": "Q1980504",
      "question_audio": null,
      "question_video": null,
      "map_id": 13400628,
      "difficulty_level": "intermediate",
      "subjects_id": [
        8
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Amitriptyline</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Amitriptyline is a tricyclic antidepressant (TCA) that is known to have marked anticholinergic activity.</span></li><li><span style=\"font-size:12.0pt;\">TCAs have high affinity for muscarinic acetylcholine (M type) receptors, causing the subsequent blockade of these receptors.</span></li><li><span style=\"font-size:12.0pt;\">Blocking of these receptors can result in decreased outflow of aqueous humour, leading to an increase in intraocular pressure.</span></li><li><span style=\"font-size:12.0pt;\">This effect can exacerbate pre-existing angle-closure type glaucoma, which is already characterized by impaired drainage of aqueous humour.</span></li><li><span style=\"font-size:12.0pt;\">Therefore, amitriptyline is a drug to be avoided in patients with angle-closure glaucoma.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Options B and D:</strong> <strong>Sertraline and Fluvoxamine</strong> are selective serotonin reuptake inhibitors with no activity at the muscarinic cholinergic receptors and therefore have no effect on the outflow of aqueous humor and thereby, on the intraocular pressure.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C:</strong> <strong>Mirtazapine </strong>is an atypical antidepressant that is a serotonin-norephedrine reuptake inhibitor with the ability to precipitate angle-closure glaucoma by itself; however, due to lack of any activity at the muscarinic cholinergic receptors, it does not increase the intraocular pressure to the extent that Amitriptyline does.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In patients with angle-closure glaucoma, medications with anticholinergic properties, such as Amitriptyline, should be avoided due to their potential to increase intraocular pressure and exacerbate the condition.</span></p>",
      "correct_choice_id": 52494,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13121,
      "choices": [
        {
          "id": 52446,
          "text": "<p><span style=\"font-size:12.0pt;\">Central retinal artery occlusion</span></p>"
        },
        {
          "id": 52447,
          "text": "<p><span style=\"font-size:12.0pt;\">Diabetic Macular edema</span></p>"
        },
        {
          "id": 52448,
          "text": "<p><span style=\"font-size:12.0pt;\">Primary open angle glaucoma</span></p>"
        },
        {
          "id": 52449,
          "text": "<p><span style=\"font-size:12.0pt;\">Non-infectious uveitis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What was ETDRS study related to? (</span>AIIMS Nov 2019)</p>",
      "unique_key": "Q7125858",
      "question_audio": null,
      "question_video": null,
      "map_id": 13400629,
      "difficulty_level": "beginner",
      "subjects_id": [
        8
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Diabetic Macular edema</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Early Treatment Diabetic Retinopathy Study (ETDRS) was a clinical trial.</span></li><li><span style=\"font-size:12.0pt;\">The study investigated the effect of photocoagulation on diabetic macular edema.</span></li><li><span style=\"font-size:12.0pt;\">The study demonstrated that focal photocoagulation was beneficial in treating diabetic macular edema.</span></li><li><span style=\"font-size:12.0pt;\">The study recommended that eyes with clinically significant diabetic macular edema should be considered for focal photocoagulation.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Central retinal artery occlusion:</strong> Not the focus of the ETDRS; this condition involves sudden, painless vision loss due to an occlusion in the central retinal artery.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Primary open angle glaucoma:</strong> Not related to the ETDRS, which did not address glaucoma treatments or outcomes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Non-infectious uveitis:</strong> Also unrelated to the ETDRS, as the study was specific to diabetic retinopathy and macular edema, not inflammatory eye diseases.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The ETDRS study established the beneficial effects of photocoagulation in treating diabetic macular edema, recommending it as an early treatment option to prevent vision loss in patients with clinically significant macular edema.</span></p>",
      "correct_choice_id": 52447,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13127,
      "choices": [
        {
          "id": 52470,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 2, 3, 4 and 5</span></p>"
        },
        {
          "id": 52471,
          "text": "<p><span style=\"font-size:12.0pt;\">2 and 3 only</span></p>"
        },
        {
          "id": 52472,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 4 and 5 only</span></p>"
        },
        {
          "id": 52473,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 3 and 4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following helps to differentiate a fixed dilated pupil? (</span>INICET Nov 2020)</p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Phenylephrine</span></li><li><span style=\"font-size:12.0pt;\">1% Pilocarpine</span></li><li><span style=\"font-size:12.0pt;\">0.1% Pilocarpine</span></li><li><span style=\"font-size:12.0pt;\">Cocaine 0.5%</span></li><li><span style=\"font-size:12.0pt;\">Epinephrine</span></li></ol>",
      "unique_key": "Q4216485",
      "question_audio": null,
      "question_video": null,
      "map_id": 13400630,
      "difficulty_level": "intermediate",
      "subjects_id": [
        8
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>B) 2 and 3 only</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Pilocarpine is used to differentiate fixed dilated pupils.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">2. 1% Pilocarpine</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/05/screenshot-2024-07-05-120120.png\" alt=\"\" width=\"1000\" height=\"364\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">3. 0.1% Pilocarpine</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/25/picture97.jpg\" alt=\"\" width=\"1000\" height=\"150\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>1. Phenylephrine:</strong> This is a sympathomimetic agent that typically dilates the pupil and is not used for differentiating causes of fixed dilation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>4. Cocaine 0.5%:</strong> Cocaine tests for anisocoria primarily in the context of Horner’s syndrome. It blocks the reuptake of norepinephrine, failing to dilate a Horner’s pupil due to sympathetic chain lesion.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/25/picture98.jpg\" alt=\"\" width=\"1000\" height=\"144\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Note - </strong>Cocaine and 1% hydroxy amphetamine are used to evaluate anisocoria in smaller pupil.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/25/picture99.jpg\" alt=\"\" width=\"1000\" height=\"298\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>5. Epinephrine:</strong> Similar to phenylephrine, epinephrine is not used to differentiate fixed dilated pupils but rather to induce dilation for diagnostic or therapeutic purposes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Pilocarpine at concentrations of 1% and 0.1% is crucial for differentiating causes of fixed dilated pupils, with 1% identifying pharmacological blockade or nerve palsy, and 0.1% detecting hypersensitivity in cases like Adie's pupil.</span></p>",
      "correct_choice_id": 52471,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13951,
      "choices": [
        {
          "id": 55765,
          "text": "<p><span style=\"font-size:12.0pt;\">Trichiasis</span></p>"
        },
        {
          "id": 55766,
          "text": "<p><span style=\"font-size:12.0pt;\">Distichiasis</span></p>"
        },
        {
          "id": 55767,
          "text": "<p><span style=\"font-size:12.0pt;\">Tylosis</span></p>"
        },
        {
          "id": 55768,
          "text": "<p><span style=\"font-size:12.0pt;\">Madarosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Extra row of eyelashes behind the grey line is called as? (</span>NEET PG 2020)</p>",
      "unique_key": "Q3437564",
      "question_audio": null,
      "question_video": null,
      "map_id": 13400631,
      "difficulty_level": "beginner",
      "subjects_id": [
        8
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. Distichiasis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Distichiasis refers to the additional row of eyelashes behind the grey line. It may happen as a result of inherited or acquired factors.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The cornea may become irritated by these lashes. The treatment involves separating the lids and applying cryotherapy to the hair follicles' bases.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/03/untitled-138.jpg\" alt=\"\" width=\"300\" height=\"208\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Trichiasis:</strong> Refers to the misdirection of eyelashes that grow inward towards the eye, causing irritation and potential damage to the cornea. The lid margin remains in its normal position.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Tylosis:</strong> Refers to the thickening of the tarsal plate, often associated with chronic inflammation and lid margin disease, but not related to an extra row of eyelashes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Madarosis:</strong> Refers to the loss of eyelashes or eyebrows, which can be due to various causes including trauma, systemic diseases, and dermatologic conditions.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Distichiasis is the condition where an extra row of eyelashes grows behind the normal lash line, often leading to corneal irritation and requiring treatment such as cryotherapy or electrolysis to prevent complications.</span></p>",
      "correct_choice_id": 55766,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11453,
      "choices": [
        {
          "id": 45778,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Leflunomide</span></span></span></span></p>"
        },
        {
          "id": 45779,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Febuxostat</span></span></span></span></p>"
        },
        {
          "id": 45780,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Methotrexate</span></span></span></span></p>"
        },
        {
          "id": 45781,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Etanercept</span></span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following drugs is not used in rheumatoid arthritis? (AIIMS MAY 2018)</span></span></p>",
      "unique_key": "Q8571964",
      "question_audio": null,
      "question_video": null,
      "map_id": 13400632,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Febuxostat</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Febuxostat is not used in the treatment of rheumatoid arthritis. It is a xanthine oxidase inhibitor primarily used as a hypouricemic agent for managing gout by reducing uric acid production. Its primary function is to alleviate the symptoms and prevent the recurrence of gout, not to treat inflammatory or autoimmune conditions like rheumatoid arthritis.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;<strong>A. Leflunomide:</strong> Incorrect choice for the given answer as Leflunomide is indeed used in the treatment of rheumatoid arthritis. It is a disease-modifying antirheumatic drug (DMARD) that works by suppressing the immune system to reduce inflammation.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option</strong>&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>C. Methotrexate:</strong> Incorrect because Methotrexate is a cornerstone treatment for rheumatoid arthritis. It is another DMARD that helps reduce joint damage and decrease the pain and swelling associated with RA.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option</strong>&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>D. Etanercept:</strong> Incorrect as it is also used in rheumatoid arthritis treatment. Etanercept is a TNF (tumor necrosis factor) inhibitor, which is a type of biologic therapy that helps to decrease inflammation and slow disease progression in RA.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Febuxostat is specifically used to manage gout by lowering uric acid levels and does not have a role in the treatment regimen for rheumatoid arthritis, which typically involves DMARDs and biologic agents aimed at controlling systemic inflammation and preventing joint damage.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reference - Harrison/Rheumatology/RA/Chap 358</span></span></strong></span></span></p>",
      "correct_choice_id": 45779,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 48993,
      "choices": [
        {
          "id": 195547,
          "text": "<p><span style=\"font-size:12.0pt;\">With the rule astigmatism</span></p>"
        },
        {
          "id": 195548,
          "text": "<p><span style=\"font-size:12.0pt;\">&nbsp;Against the rule astigmatism</span></p>"
        },
        {
          "id": 195549,
          "text": "<p><span style=\"font-size:12.0pt;\">&nbsp;Simple astigmatism</span></p>"
        },
        {
          "id": 195550,
          "text": "<p><span style=\"font-size:12.0pt;\">&nbsp;Mixed astigmatism</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">A patient is prescribed a corrective lens with the following prescription: -1D spherical, -2D cylinder at 180 degrees. What type of refractive error is being corrected?&nbsp;(INICET Nov 2023)</span></p>",
      "unique_key": "Q9973122",
      "question_audio": null,
      "question_video": null,
      "map_id": 13400633,
      "difficulty_level": "intermediate",
      "subjects_id": [
        8
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) With the rule astigmatism</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">In the context of refractive errors corrected by lenses, here's an explanation of each type of astigmatism as mentioned:</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In this condition, the eye's steepest curve is oriented vertically (up and down). This is the most common type of astigmatism. The -2D cylindrical correction at 180 degrees indicates that the correction is applied horizontally, which compensates for the steeper vertical curvature.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Against the Rule Astigmatism</strong>: Here, the steepest curvature is horizontal (side to side). Corrective lenses for this type would have cylindrical axes oriented vertically (usually at 90 degrees).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Simple Astigmatism</strong>: This occurs when one principal meridian is emmetropic (normal), meaning no refractive error, while the other has myopia (short-sightedness) or hyperopia (long-sightedness). There is only one refractive error to correct.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Mixed Astigmatism</strong>: This type features one meridian with myopia and the perpendicular meridian with hyperopia. Essentially, one axis is near sighted, and the other is farsighted, requiring complex lens corrections to address both issues simultaneously.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong>&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">When prescribed corrective lenses for astigmatism, understanding the orientation and type of astigmatism (with the rule, against the rule, simple, or mixed) is crucial for ensuring the correct lens type and orientation is used, thus maximizing visual clarity and health.</span></p>",
      "correct_choice_id": 195547,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13150,
      "choices": [
        {
          "id": 52561,
          "text": "<p><span style=\"font-size:12.0pt;\">Rate of recurrence is 95%.</span></p>"
        },
        {
          "id": 52562,
          "text": "<p><span style=\"font-size:12.0pt;\">It is a fibrovascular growth.</span></p>"
        },
        {
          "id": 52563,
          "text": "<p><span style=\"font-size:12.0pt;\">The parts of a pterygium are Body, head and cap</span></p>"
        },
        {
          "id": 52564,
          "text": "<p><span style=\"font-size:12.0pt;\">Has progressive and regressive types.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is not a feature of pterygium? (</span>INICET Nov 2022)</p>",
      "unique_key": "Q5436835",
      "question_audio": null,
      "question_video": null,
      "map_id": 13400634,
      "difficulty_level": "intermediate",
      "subjects_id": [
        8
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Rate of recurrence is 95%</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Pterygium is a triangular fibrovascular ingrowth of degenerative conjunctival tissue.</span></li><li><span style=\"font-size:12.0pt;\">It is caused by prolonged exposure to UV rays, dry heat, etc.</span></li><li><span style=\"font-size:12.0pt;\">It has three parts: head (apical part on the cornea, body (region between limbus and canthus), and cap (semilunar white infiltrate in front of the head).</span></li><li><span style=\"font-size:12.0pt;\">Patients may experience itching and grittiness due to Dellen.</span></li><li><span style=\"font-size:12.0pt;\">It can interfere with vision and induce astigmatism.</span></li><li><span style=\"font-size:12.0pt;\">Stocker's line may be associated with pterygium, which is a linear deposition of iron seen in the corneal epithelium, anterior to the head of a pterygium.</span></li><li><span style=\"font-size:12.0pt;\">The recurrence rate after simple surgical excision is around 80%.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/29/picture7_mN5l2bY.jpg\" alt=\"\" width=\"300\" height=\"200\"></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Pterygium is of 2 types:&nbsp;</span><ol style=\"list-style-type:lower-roman;\"><li><span style=\"font-size:12.0pt;\">Progressive which is thick, fleshy, and vascular.</span></li><li><span style=\"font-size:12.0pt;\">Regressive which is thin, atrophic, and attenuated.</span></li></ol></li><li><span style=\"font-size:12.0pt;\">This condition can be treated symptomatically with tear substitutes for dry eye symptoms and patients are advised to avoid &nbsp;exposure to sun.</span></li><li><span style=\"font-size:12.0pt;\">Surgical excision with free conjunctival limbal autograft is the preferred treatment to avoid recurrence.</span></li><li><span style=\"font-size:12.0pt;\">The recurrence rate of pterygium is around 80% after simple surgical excision. Excision together with adjunctive therapies such as mitomycin C or 5-fluorouracil can reduce the risk of recurrence to approximately 10%.</span></li><li><span style=\"font-size:12.0pt;\">Reported Recurrence rate after P.E.R.F.E.C.T technique is 1.6% (Cornelius CR. Recurrence Rate and Complications of Pterygium Extended Removal Followed by Extended Conjunctival Transplant).</span></li></ul><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/05/screenshot-2024-07-05-143100.png\" alt=\"\" width=\"1000\" height=\"977\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. It is a fibrovascular growth</strong>: This is accurate. Pterygium consists of fibrovascular tissue that can progressively invade the cornea.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. The parts of a pterygium are Body, head and cap</strong>: This is true. The pterygium is typically described as having three parts: the head (which is the part that extends onto the cornea), the body (the main bulk of the growth), and the cap or leading edge.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Has progressive and regressive types</strong>: This is also true. Pterygium can be classified into progressive, which is active, vascular, and may encroach further onto the cornea, and regressive, which is typically less vascular and more fibrotic.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Pterygium's recurrence after surgical removal depends greatly on the surgical technique and the use of adjuvant therapies, not inherently 95% as previously thought. Effective management includes surgical excision combined with conjunctival autografts and adjuvant therapy to reduce the risk of recurrence significantly.</span></p>",
      "correct_choice_id": 52561,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13788,
      "choices": [
        {
          "id": 55113,
          "text": "<p><span style=\"font-size:12.0pt;\">Right gastric and right gastroepiploic artery</span></p>"
        },
        {
          "id": 55114,
          "text": "<p><span style=\"font-size:12.0pt;\">Right gastric and left gastric artery</span></p>"
        },
        {
          "id": 55115,
          "text": "<p><span style=\"font-size:12.0pt;\">Right gastroepiploic and short gastric vessels</span></p>"
        },
        {
          "id": 55116,
          "text": "<p><span style=\"font-size:12.0pt;\">Right gastric and short gastric vessels</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Ligation of the common hepatic artery would most likely compromise the blood supply to which of the following arteries? (NEET PG 2020)</span></p>",
      "unique_key": "Q9617845",
      "question_audio": null,
      "question_video": null,
      "map_id": 13400635,
      "difficulty_level": "beginner",
      "subjects_id": [
        3
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A. Right gastric and right gastroepiploic artery</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Ligation of the common hepatic artery will cause impairment in the blood supply through its branches i.e., right gastric artery and right gastroepiploic artery.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/07/04/untitled-887.jpg\" alt=\"\" width=\"600\" height=\"359\"></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The common hepatic artery typically divides into the hepatic proper artery and the gastroduodenal artery.</span></li><li><span style=\"font-size:12.0pt;\">The hepatic proper artery, in turn, gives rise to the right gastric artery (which supplies the lesser curvature of the stomach) and continues as the left and right hepatic arteries for the liver.</span></li><li><span style=\"font-size:12.0pt;\">The gastroduodenal artery gives off the right gastroepiploic artery, which supplies the greater curvature of the stomach.</span></li><li><span style=\"font-size:12.0pt;\">Thus, if the common hepatic artery is ligated, blood supply to both the right gastric and right gastroepiploic arteries would be impaired.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Branches of hepatic artery (Mnemonic – Girls R So Cute)</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>G</strong>astroduodenal artery &gt; divides into right gastroepiploic and superior pancreaticoduodenal arteries.</span></li><li><span style=\"font-size:12.0pt;\"><strong>R</strong>ight gastric artery</span></li><li><span style=\"font-size:12.0pt;\"><strong>S</strong>upra duodenal artery (inconstant)</span></li><li><span style=\"font-size:12.0pt;\"><strong>C</strong>ystic artery</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Right gastric and left gastric artery</strong>: While the right gastric artery does arise from the hepatic proper artery (a branch of the common hepatic artery), the left gastric artery arises directly from the celiac trunk. Ligation of the common hepatic artery would not affect the left gastric artery's blood supply.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Right gastroepiploic and short gastric vessels</strong>: The right gastroepiploic artery arises from the gastroduodenal artery (a branch of the common hepatic artery). The short gastric arteries, however, typically arise from the splenic artery, another direct branch of the celiac trunk. Therefore, ligation of the common hepatic artery would not affect the blood supply of the short gastric vessels.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Right gastric and short gastric vessels</strong>: As mentioned earlier, the right gastric artery arises from the hepatic proper artery. The short gastric arteries arise from the splenic artery. Ligation of the common hepatic artery would only affect the right gastric artery's blood supply, not the short gastric vessels.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Ligation of the common hepatic artery affects the blood supply to both the right gastric and right gastroepiploic arteries due to their derivation from the hepatic proper and gastroduodenal arteries respectively.</span></p>",
      "correct_choice_id": 55113,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "InvestigationBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20271,
      "choices": [
        {
          "id": 81045,
          "text": "<p><span style=\"font-size:12.0pt;\">DDAVP for 2 weeks and then discontinue</span></p>"
        },
        {
          "id": 81046,
          "text": "<p><span style=\"font-size:12.0pt;\">DDAVP supplementation for lifelong</span></p>"
        },
        {
          "id": 81047,
          "text": "<p><span style=\"font-size:12.0pt;\">Upsetting of receptors so no treatment is required</span></p>"
        },
        {
          "id": 81048,
          "text": "<p><span style=\"font-size:12.0pt;\">Thiazides for 2 weeks</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient came to the medical OPD with complaints of polyuria. He has a history of undergoing total hypophysectomy. His Na<sup>+</sup> levels are found to be 155 mEq/L, urine osmolality was 200 mOsm/L. What is the definitive management? (NEET PG 2023)</span></p>",
      "unique_key": "Q6225083",
      "question_audio": null,
      "question_video": null,
      "map_id": 13400636,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.&nbsp;B. DDAVP supplementation for lifelong</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient's presentation of polyuria and low urine osmolality (200 mOsm/L) with hypernatremia (Na+ 155 mEq/L) is indicative of diabetes insipidus (DI). Given the history of total hypophysectomy, this is most likely central diabetes insipidus (CDI), where the pituitary gland no longer produces antidiuretic hormone (ADH, also known as vasopressin).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In CDI, the definitive treatment is <strong>desmopressin (DDAVP</strong>), a synthetic analog of ADH. Desmopressin helps to reduce urine output and correct hypernatremia by promoting water reabsorption in the kidneys. Since the condition is permanent due to the hypophysectomy, lifelong supplementation with desmopressin is necessary.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;A. DDAVP for 2 weeks and then discontinue:</strong> Discontinuing DDAVP after 2 weeks is not appropriate as the patient will continue to suffer from polyuria and hypernatremia due to the lack of ADH.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;C. Upsetting of receptors so no treatment is required</strong>: This option is incorrect as the patient's symptoms and lab findings clearly indicate the need for treatment.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;D. Thiazides for 2 weeks:</strong> Thiazides are used in nephrogenic diabetes insipidus (NDI) to reduce urine output by increasing ADH sensitivity. However, in central diabetes insipidus, thiazides are not effective because the issue is the absence of ADH, not a problem with the kidneys' response to it.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In patients with central diabetes insipidus following total hypophysectomy, lifelong desmopressin (DDAVP) supplementation is required to manage symptoms and prevent complications from persistent polyuria and hypernatremia.</span></p>",
      "correct_choice_id": 81046,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 60495,
      "choices": [
        {
          "id": 241273,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Horizontal gaze palsy&nbsp; </span></span></span></p>"
        },
        {
          "id": 241274,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Internuclear ophthalmoplegia&nbsp; </span></span></span></p>"
        },
        {
          "id": 241275,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">3rd nerve palsy&nbsp; </span></span></span></p>"
        },
        {
          "id": 241276,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Duane retraction syndrome&nbsp;</span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The given image illustrates which of the following conditions? (AIIMS NOV 2016)</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/09/picture1.jpg\" style=\"height:411px; width:400px\" /></span></span></p>",
      "unique_key": "Q4162387",
      "question_audio": null,
      "question_video": null,
      "map_id": 13400637,
      "difficulty_level": "intermediate",
      "subjects_id": [
        8
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Correct Answer: B. Internuclear ophthalmoplegia</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The image shows an attempt at lateral gaze away from the lesion side, where the abducting eye overshoots the target, leading to dissociated nystagmus. This feature is characteristic of internuclear ophthalmoplegia, where there is a lesion in the medial longitudinal fasciculus, disrupting communication between the abducens nucleus and the contralateral medial rectus subnucleus. This condition affects the adduction of the ipsilateral eye during saccades, causing either slow or absent movement. If the internuclear ophthalmoplegia is bilateral, the abduction saccades may also be impaired.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other options:</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>Option A. Horizontal gaze palsy</strong>: This condition involves the inability to move both eyes in the same direction, typically without the dissociated nystagmus seen in internuclear ophthalmoplegia.</span></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Third nerve palsy</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: It is usually associated with symptoms like ptosis, eye deviation down and out, and pupil dilation, none of which are seen in the image provided.</span></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Duane retraction syndrome</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This is a congenital condition where the eye movement is restricted due to abnormal development of the cranial nerves. The findings in the image do not align with this condition&#39;s characteristic restricted abduction or adduction.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Internuclear ophthalmoplegia is characterized by impaired adduction of the affected eye and dissociated nystagmus in the abducting eye during lateral gaze.</span></span></span></p>",
      "correct_choice_id": 241274,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54518,
      "choices": [
        {
          "id": 217541,
          "text": "<p><span style=\"font-size:12.0pt;\">RBC pipette</span></p>"
        },
        {
          "id": 217542,
          "text": "<p><span style=\"font-size:12.0pt;\">Sahli graduated hemoglobin tube</span></p>"
        },
        {
          "id": 217543,
          "text": "<p><span style=\"font-size:12.0pt;\">Comparator with brown glass standard</span></p>"
        },
        {
          "id": 217544,
          "text": "<p><span style=\"font-size:12.0pt;\">Hemoglobin pipette</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is not useful for hemoglobin estimation by the colorimetric test?&nbsp;</span>&nbsp;(INICET MAY 2024)</p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/23/screenshot-2024-08-23-132314.png\" alt=\"\" width=\"300\" height=\"131\"></p>",
      "unique_key": "Q6423065",
      "question_audio": null,
      "question_video": null,
      "map_id": 13400638,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.&nbsp;A) RBC pipette</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The RBC pipette, identifiable by its red bead, is primarily used for counting red blood cells in a blood sample. It is not suitable for the colorimetric estimation of hemoglobin, as it is not designed for colorimetric comparisons or for mixing the reagents involved in this method.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The colorimetric method for hemoglobin estimation, often referred to as Sahli's method, relies on comparing the color intensity of a hemoglobin solution to a standard comparator. The primary steps involve mixing a blood sample with N/10 HCl in a graduated hemoglobin tube, which then undergoes color comparison against a brown glass standard.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Key Tools Used in Sahli's Method:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Sahli graduated hemoglobin tube</strong>: Used to mix blood with hydrochloric acid and measure the resulting color intensity.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Comparator with brown glass standard</strong>: Helps in comparing the color of the hemoglobin solution to determine the concentration.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Hemoglobin pipette</strong>: Utilized to accurately measure and transfer the blood sample into the graduated hemoglobin tube.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The RBC pipette is not useful for hemoglobin estimation by the colorimetric (Sahli's) method, as it is designed for cell counting rather than for the preparation and color comparison required in this test.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Summary Table:</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_PWbCTrg.png\" width=\"1428\" height=\"360\"></span></p>",
      "correct_choice_id": 217541,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased",
        "INICET",
        "InstrumentsBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 32315,
      "choices": [
        {
          "id": 129114,
          "text": "<p><span style=\"font-size:12.0pt;\">Vitamin A</span></p>"
        },
        {
          "id": 129115,
          "text": "<p><span style=\"font-size:12.0pt;\">Vitamin B</span></p>"
        },
        {
          "id": 129116,
          "text": "<p><span style=\"font-size:12.0pt;\">Vitamin C</span></p>"
        },
        {
          "id": 129117,
          "text": "<p><span style=\"font-size:12.0pt;\">Vitamin K</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Condition shown below is due to which vitamin deficiency?(NEET PG 2022)</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/05/picture15.jpg\" alt=\"\" width=\"300\" height=\"195\"></span></p>",
      "unique_key": "Q3375294",
      "question_audio": null,
      "question_video": null,
      "map_id": 13400639,
      "difficulty_level": "beginner",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Vitamin A</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This is Bitot’s spot shown in the picture due to vitamin A deficiency. There is build-up of keratin located superficially in conjunctiva. This can be oval, triangular or irregular in shape. This is also associated with conjunctival xerosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p><span style=\"font-size:11pt;\"><strong>&nbsp;</strong></span></p><p><span style=\"font-size:12.0pt;\"><strong>Option B</strong>.&nbsp;<strong>Vitamin B:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Function:&nbsp;</strong>Vitamin B is a group of vitamins that includes B1 (thiamine), B2 (riboflavin), B3 (niacin), B5 (pantothenic acid), B6 (pyridoxine), B7 (biotin), B9 (folate), and B12 (cobalamin). These vitamins play various roles in energy production, brain function, and cell metabolism</span></li><li><span style=\"font-size:12.0pt;\"><strong>Deficiency Symptoms:&nbsp;</strong>Deficiencies in different B vitamins can result in a range of symptoms, including fatigue, neurological issues, anemia, and skin problems.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C</strong>.&nbsp;<strong>Vitamin C:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Function:&nbsp;</strong>Vitamin C is essential for the synthesis of collagen, wound healing, and the absorption of iron from plant-based foods. It also acts as an antioxidant, protecting cells from damage.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Deficiency Symptoms:&nbsp;</strong>A lack of vitamin C can lead to scurvy, which includes symptoms such as bleeding gums, joint pain, and skin issues.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D</strong>.&nbsp;<strong>Vitamin K:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Function:&nbsp;</strong>Vitamin K is crucial for blood clotting and bone health. It helps in the synthesis of proteins involved in clot formation and bone mineralization.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Deficiency Symptoms:&nbsp;</strong>Vitamin K deficiency can result in bleeding disorders and weakened bones.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Function:&nbsp;</strong>Vitamin A plays a vital role in the growth and development of human cells, controlling the immune system by preventing infections, and activating white blood cells</span></li><li><span style=\"font-size:12.0pt;\"><strong>Deficiency Symptoms:&nbsp;</strong>Vitamin A deficiency can lead to night blindness, dry skin, poor immune function, and impaired growth and development.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Reference</u>: Harper’s 31<sup>st</sup> ed/pg- 530</strong></span></p>",
      "correct_choice_id": 129114,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 24719,
      "choices": [
        {
          "id": 98837,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Zavegepant</span></span></span></p>"
        },
        {
          "id": 98838,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Trofinetide</span></span></span></p>"
        },
        {
          "id": 98839,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Sparsentan</span></span></span></p>"
        },
        {
          "id": 98840,
          "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Elacestrant</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Which of the following is a new approved drug for Rett syndrome. (</span></span></span>INICET May 2023)</p>",
      "unique_key": "Q7148277",
      "question_audio": null,
      "question_video": null,
      "map_id": 13400640,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B. Trofinetide</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Rett syndrome is an X-linked genetic disorder mostly seen in females. <span style=\"background-color:white\"><span style=\"color:#202122\">Symptoms include impairments in language and coordination, and repetitive movements. It occurs due to mutation in MECP2 gene.</span></span></span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Trofinetide is an analog of&nbsp;glypromate&nbsp;or glycine&ndash;proline&ndash;glutamate (GPE), a naturally occurring protein in the brain and the N-terminal tripeptide of insulin-like growth factor 1 (IGF-1). GPE exhibits neuroprotective properties: it protects neurons from glutamate-mediated excitotoxicity and oxidative stress. </span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Trofinetide has similar neuroprotective properties and has longer half-life.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<h3><span style=\"font-size:13.5pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></h3>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Zavegepant</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This is a CGRP antagonist approved for the treatment of migraine, not for Rett syndrome.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Sparsentan</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This is a dual endothelin antagonist and angiotensin receptor antagonist approved for the treatment of IgA nephropathy, not Rett syndrome.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Elacestrant</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This is a selective estrogen receptor downregulator approved as an oral treatment for breast cancer, not Rett syndrome.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Trofinetide is a newly approved drug for Rett syndrome, exhibiting neuroprotective properties similar to those of glypromate (GPE), and is beneficial for treating the symptoms of this genetic disorder.</span></span></span></p>",
      "correct_choice_id": 98838,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 51036,
      "choices": [
        {
          "id": 203673,
          "text": "<p><span style=\"font-size:12pt;\">2 and 5</span></p>"
        },
        {
          "id": 203674,
          "text": "<p><span style=\"font-size:12pt;\">3 and 4</span></p>"
        },
        {
          "id": 203675,
          "text": "<p><span style=\"font-size:12pt;\">1 and 3</span></p>"
        },
        {
          "id": 203676,
          "text": "<p><span style=\"font-size:12pt;\">2 and 4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following muscles are supplied by the lateral plantar nerve? (</span>INICET Nov 2023)</p><p>&nbsp;</p><ol><li><span style=\"font-size:12pt;\">Abductor hallucis</span></li><li><span style=\"font-size:12pt;\">Flexor digitorum accessorius</span></li><li><span style=\"font-size:12pt;\">Flexor hallucis brevis</span></li><li><span style=\"font-size:12pt;\">First lumbrical</span></li><li><span style=\"font-size:12pt;\">First interossei</span></li></ol>",
      "unique_key": "Q1326947",
      "question_audio": null,
      "question_video": null,
      "map_id": 13400641,
      "difficulty_level": "difficult",
      "subjects_id": [
        3
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) 2 and 5</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/04/screenshot-2024-07-04-102502_Vdv1wE0.png\" alt=\"\" width=\"600\" height=\"276\"></strong></span></p><p>&nbsp;</p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The lateral plantar nerve is a branch of the tibial nerve, which innervates various muscles in the sole of the foot. It divides into superficial and deep branches, each supplying specific muscles.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Flexor Digitorum Accessorius :</strong> This muscle assists in the flexion of the toes and is supplied by the lateral plantar nerve.</span></li><li><span style=\"font-size:12pt;\"><strong>First Interossei:</strong> The interossei muscles, which include the dorsal and plantar interossei, are responsible for abduction and adduction of the toes. The first interossei is supplied by the lateral plantar nerve.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>1. Abductor hallucis:</strong> This muscle is supplied by the medial plantar nerve, not the lateral plantar nerve.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>3. Flexor hallucis brevis:</strong> This muscle is also supplied by the medial plantar nerve.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>4. First lumbrical:</strong> The first lumbrical is supplied by the medial plantar nerve, whereas the second, third, and fourth lumbricals are supplied by the lateral plantar nerve.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The lateral plantar nerve supplies the flexor digitorum accessorius (quadratus plantae) and the first interossei muscles in the foot.</span></p>",
      "correct_choice_id": 203673,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14004,
      "choices": [
        {
          "id": 55977,
          "text": "<p><span style=\"font-size:12.0pt;\">Heavyweight with small pores</span></p>"
        },
        {
          "id": 55978,
          "text": "<p><span style=\"font-size:12.0pt;\">Heavyweight mesh with large pores</span></p>"
        },
        {
          "id": 55979,
          "text": "<p><span style=\"font-size:12.0pt;\">Lightweight mesh with small pores</span></p>"
        },
        {
          "id": 55980,
          "text": "<p><span style=\"font-size:12.0pt;\">Lightweight mesh with large pores</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 45-year-old male presents to the surgeon with a recurrent inguinal hernia. The surgeon decides to perform a hernioplasty, and the patient inquiries about the most appropriate type of mesh to be used. The surgeon wants to ensure that the patient is aware of the various types of meshes that can be used in hernioplasty. Which of the following is the most appropriate mesh for use in hernioplasty? (AIIMS MAY 2020)</span></p>",
      "unique_key": "Q5571880",
      "question_audio": null,
      "question_video": null,
      "map_id": 13400642,
      "difficulty_level": "intermediate",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Lightweight mesh with large pores</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Lightweight meshes with large pores are considered <strong>the most appropriate choice for hernioplasty.</strong> They provide adequate support to repair the hernia while allowing for better tissue integration and reduced inflammation. This type of mesh is associated with lower postoperative pain and discomfort.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Heavyweight mesh:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Heavyweight meshes are typically not recommended for hernioplasty because they can lead to increased inflammation, tissue response, and a higher risk of complications. They may cause stiffness and discomfort in the area.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The most appropriate mesh to use in hernioplasty is a lightweight mesh with large pores.</span></li><li><span style=\"font-size:12.0pt;\">Lightweight meshes induce a less-pronounced foreign body reaction and decreased inflammatory response, leading to better tissue incorporation, increased prosthesis compliance, and decreased patient discomfort and pain.</span></li><li><span style=\"font-size:12.0pt;\">Meshes with large pores allow for increased soft tissue ingrowth and exhibit less inflammatory infiltrate, connective tissue, and scar bridging. This results in less adhesion, better tissue incorporation, and decreased patient discomfort and pain.</span></li><li><span style=\"font-size:12.0pt;\">“Meshes with thinner strands and larger spaces (pores) between them are preferred because they have better tissue integration, less contracture, less foreign body reaction, more flexibility and improved comfort.” Bailey 28<sup>th</sup> Ed. Pg 1063.</span></li><li><span style=\"font-size:12.0pt;\">Meshes used in hernioplasty can be synthetic or biological, with synthetic meshes made from Polypropylene, Polyester, or PTFE.</span></li></ul>",
      "correct_choice_id": 55980,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14439,
      "choices": [
        {
          "id": 57717,
          "text": "<p><span style=\"font-size:12pt;\">Neck</span></p>"
        },
        {
          "id": 57718,
          "text": "<p><span style=\"font-size:12pt;\">Chest</span></p>"
        },
        {
          "id": 57719,
          "text": "<p><span style=\"font-size:12pt;\">Median sternotomy</span></p>"
        },
        {
          "id": 57720,
          "text": "<p><span style=\"font-size:12pt;\">None of the above</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Mrs. Kumar, a 60-year-old woman, has been experiencing difficulty swallowing and a feeling of pressure in her chest. Her doctor orders an ultrasound, which reveals a retrosternal goiter. The commonest surgical approach to a retrosternal goiter is via: (NEET PG 2019)</span></p>",
      "unique_key": "Q2942212",
      "question_audio": null,
      "question_video": null,
      "map_id": 13400643,
      "difficulty_level": "beginner",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A. Neck</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The commonest surgical approach to a retrosternal goiter is via the neck. This is because the thyroid gland is anatomically located in the neck, and even when a goiter extends behind the sternum into the chest, the neck provides the most direct and least invasive access for surgical removal. The retrosternal portion of the goiter can usually be mobilized and delivered into the neck for excision without the need for more invasive thoracic approaches. The vascular supply of the goiter also predominantly comes from cervical vessels like the inferior thyroid artery, making the neck approach feasible and effective.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Chest:&nbsp;</strong>Surgical approaches through the chest are typically not used for retrosternal goiters. Accessing the thyroid gland through the chest would involve more invasive procedures, such as thoracotomy, and is generally reserved for rare cases with specific indications, such as very large goiters extending deeply into the chest cavity.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Median Sternotomy:&nbsp;</strong>Median sternotomy involves cutting through the breastbone (sternum) to access structures within the chest, particularly the heart and major blood vessels. While median sternotomy is common for cardiac surgeries, it is not the primary approach for treating retrosternal goiters, which can typically be addressed via the neck.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. None of the above:&nbsp;</strong>This option is incorrect because the neck is the commonest and preferred approach for the surgical removal of retrosternal goiters.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The most common and preferred surgical approach for a retrosternal goiter is via the neck due to its direct access to the thyroid gland and the feasibility of mobilizing the goiter from this region.</span></p>",
      "correct_choice_id": 57717,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "OlderNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14356,
      "choices": [
        {
          "id": 57385,
          "text": "<p><span style=\"font-size:12.0pt;\">Multi-infarct dementia</span></p>"
        },
        {
          "id": 57386,
          "text": "<p><span style=\"font-size:12.0pt;\">Frontal lobe meningioma</span></p>"
        },
        {
          "id": 57387,
          "text": "<p><span style=\"font-size:12.0pt;\">Korsakoff disease</span></p>"
        },
        {
          "id": 57388,
          "text": "<p><span style=\"font-size:12.0pt;\">Subdural hematoma</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is the likely diagnosis of an old lady who sustained a fall and presented with a headache and neurological symptoms a few days later? </span><span style=\"font-size:11.0pt;\">(</span><span style=\"font-size:12.0pt;\">INICET MAY 2022)</span></p>",
      "unique_key": "Q5144733",
      "question_audio": null,
      "question_video": null,
      "map_id": 13400644,
      "difficulty_level": "beginner",
      "subjects_id": [
        9
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Subdural Hematoma</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The given clinical scenario suggests Acute Subdural Hematoma (SDH), which is the accumulation of blood between the arachnoid membrane and the dura, resulting from the tearing of a bridging vein running from the cerebral cortex to the Dural sinuses. It is commonly seen in the elderly, alcoholics, and patients on anticoagulants. The stretching of Cortical-Dural bridging veins in cerebral atrophy makes them vulnerable to rupture, leading to symptoms of raised intracranial pressure or focal deficits. On head CT scan, acute SDH appears as a hyperdense, crescent-shaped lesion.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">A subdural hematoma is a collection of blood between the layers of the dura mater surrounding the brain. It can occur as a result of head trauma, such as a fall, and may not present with immediate symptoms but can lead to a gradual onset of neurological symptoms, including headache, confusion, and other focal neurological deficits. Subdural hematomas are known to have delayed presentations after the initial trauma, making this the likely diagnosis in the context of a fall with subsequent neurological symptoms.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Multi-infarct dementia</strong>: Multi-infarct dementia, also known as vascular dementia, typically develops gradually and is associated with a history of multiple strokes or cerebral infarctions. It does not typically present acutely after a fall with neurological symptoms.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Frontal lobe meningioma</strong>: While a frontal lobe meningioma can cause neurological symptoms, it typically develops slowly and is not usually associated with an acute presentation following a fall. Additionally, the symptoms of a meningioma can vary widely depending on its location and size.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Korsakoff disease</strong>: Korsakoff disease is primarily associated with chronic alcohol abuse and is characterized by severe memory impairment. It does not typically present acutely following a fall with neurological symptoms.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Given the history of a fall and the delayed onset of neurological symptoms, a subdural hematoma (option D) is the most likely diagnosis in this case.</span></p>",
      "correct_choice_id": 57388,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 2454,
      "choices": [
        {
          "id": 9802,
          "text": "<p><span style=\"font-size:12.0pt;\">3'-5' Exonuclease</span></p>"
        },
        {
          "id": 9803,
          "text": "<p><span style=\"font-size:12.0pt;\">5'-3' Exonuclease</span></p>"
        },
        {
          "id": 9804,
          "text": "<p><span style=\"font-size:12.0pt;\">5'-&gt;3' DNA polymerase</span></p>"
        },
        {
          "id": 9805,
          "text": "<p><span style=\"font-size:12.0pt;\">3'-5' DNA polymerase</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Klenow fragment lacks the activity of? (</span>AIIMS Nov 2018)</p>",
      "unique_key": "Q1982150",
      "question_audio": null,
      "question_video": null,
      "map_id": 13400645,
      "difficulty_level": "beginner",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B)&nbsp;5'-3' Exonuclease</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">DNA polymerase I (Kornberg’s enzyme) was isolated from Escherichia coli. It is a repair enzyme. It has both 3′ to 5′ and 5′ to 3′ exonuclease activities. <strong>When 5′ to 3′ exonuclease domain is removed, the remaining fragment retains the polymerization and proofreading activities; it is then called Klenow fragment. It is widely used in recombinant DNA technology</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Details of DNA Polymerase I and Klenow Fragment:</strong></span></p><ul><li><span style=\"font-size:12.0pt;\"><strong>DNA Polymerase I (Kornberg's enzyme):</strong> This enzyme has three activities:</span><ul><li><span style=\"font-size:12.0pt;\">5'-&gt;3' polymerase activity (synthesizes DNA)</span></li><li><span style=\"font-size:12.0pt;\">3'-5' exonuclease activity (proofreading)</span></li><li><span style=\"font-size:12.0pt;\">5'-3' exonuclease activity (removes RNA primers and repairs DNA)</span></li></ul></li><li><p><span style=\"font-size:12.0pt;\"><strong>Klenow Fragment:</strong> This fragment results from removing the 5'-3' exonuclease domain. It retains:</span></p><p>&nbsp;</p></li></ul><p><span style=\"font-size:12.0pt;\">The Klenow fragment is widely used in recombinant DNA technology due to its ability to synthesize DNA and proofread without degrading the DNA template or newly synthesized strand.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>3'-5' Exonuclease:</strong> This proofreading activity is retained by the Klenow fragment.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>5'-&gt;3' DNA polymerase:</strong> This polymerization activity is also retained by the Klenow fragment.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>3'-5' DNA polymerase:</strong> This option is incorrect terminology; which is correctly termed 3'-5' exonuclease and is retained in the Klenow fragment.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The Klenow fragment of DNA polymerase I lacks the 5'-3' exonuclease activity but retains the 5'-&gt;3' polymerase and 3'-5' exonuclease (proofreading) activities, making it useful for DNA synthesis and recombinant DNA technology.</span></p>",
      "correct_choice_id": 9803,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 60496,
      "choices": [
        {
          "id": 241277,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Left Optic Nerve</span></span></span></p>"
        },
        {
          "id": 241278,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Optic Chiasma</span></span></span></p>"
        },
        {
          "id": 241279,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Right Occipital Lobe</span></span></span></p>"
        },
        {
          "id": 241280,
          "text": "<p><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Left Temporal Lobe</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">A 52-year-old man presents to the ophthalmology clinic with complaints of progressive difficulty seeing objects in his peripheral vision, particularly noticing that he often misses things on the sides while driving. He reports experiencing mild, intermittent headaches over the past few weeks. His past medical history is unremarkable, and he has no known history of trauma or other neurological issues. A visual field test is performed, and the results are displayed in the image provided. Based on these findings, what is the most likely location of the lesion?</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/09/picture12.jpg\" style=\"height:119px; width:300px\" /></span></span></span></p>",
      "unique_key": "Q8639702",
      "question_audio": null,
      "question_video": null,
      "map_id": 13400646,
      "difficulty_level": "beginner",
      "subjects_id": [
        8
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Ans.&nbsp; B. Optic Chiasma</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">The visual field defect observed in the image is characteristic of bitemporal hemianopia, which is typically caused by a lesion at the optic chiasma. The optic chiasma is the point where the optic nerves from both eyes partially cross, and a lesion here affects the crossing fibers that correspond to the temporal (lateral) visual fields of both eyes. The most common cause of such a lesion is a pituitary gland tumor, which can compress the optic chiasma as it enlarges. Other potential causes include suprasellar aneurysms, craniopharyngiomas, and meningiomas.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Option A. Left Optic Nerve:</span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"> A lesion here would result in monocular vision loss or partial vision loss in the left eye only, not the bitemporal hemianopia seen in this case.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Option C. Right Occipital Lobe:</span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"> A lesion here would typically result in a contralateral homonymous hemianopia (loss of the same side of the visual field in both eyes), not a bitemporal hemianopia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Option D. Left Temporal Lobe:</span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"> A lesion in the left temporal lobe would affect the superior quadrants of the visual field on the right side in both eyes (superior homonymous quadrantanopia), not the pattern seen here.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Bitemporal hemianopia, typically resulting from a lesion at the optic chiasma, is most commonly caused by pituitary tumors. Identifying this visual field defect is crucial as it can be a sign of a potentially serious underlying condition that requires further investigation and management.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/09/picture2_mAAVw0D.jpg\" style=\"height:682px; width:700px\" /></span></span></span></p>",
      "correct_choice_id": 241278,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7174,
      "choices": [
        {
          "id": 28664,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Weakly basic drugs</span></span></span></p>"
        },
        {
          "id": 28665,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Strong acids</span></span></span></p>"
        },
        {
          "id": 28666,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Strong bases</span></span></span></p>"
        },
        {
          "id": 28667,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Weakly acidic drugs</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Alkalinization of urine will be helpful in the treatment of poisoning due to?</span></span>(INICET NOV 2022)</p>",
      "unique_key": "Q5749584",
      "question_audio": null,
      "question_video": null,
      "map_id": 13400647,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D. Weakly acidic drugs</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Alkalinization of urine is effective in treating overdoses of weakly acidic drugs. By increasing the pH of the urine, it promotes the ionization of these drugs. Ionized drugs are less likely to be reabsorbed in the kidney tubules and are more readily excreted. This principle is particularly applied in cases of aspirin (salicylate) poisoning.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Weakly basic drugs:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Urinary alkalinization is not typically used for weakly basic drugs. Basic drugs are more likely to be reabsorbed in an alkaline environment, making this approach counterproductive.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Strong acids:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Strong acids are not significantly affected by urinary pH, so alkalinization would not be particularly beneficial.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Strong bases:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Similar to strong acids, strong bases are not significantly impacted by changes in urinary pH.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Alkalinization of urine is an effective strategy to enhance the excretion of weakly acidic drugs by increasing their ionization and reducing their reabsorption in the renal tubules, thus promoting their elimination from the body. This method is particularly useful in cases of poisoning with weak acids, such as aspirin (salicylates).</span></span></span></p>",
      "correct_choice_id": 28667,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6511,
      "choices": [
        {
          "id": 26013,
          "text": "<p><span style=\"font-size:12.0pt;\">Teriparatide can be given along with bisphosphonates.</span></p>"
        },
        {
          "id": 26014,
          "text": "<p><span style=\"font-size:12.0pt;\">Bisphosphonates are not given for more than a year</span></p>"
        },
        {
          "id": 26015,
          "text": "<p><span style=\"font-size:12.0pt;\">Calcium requirement is 1200 mg per day</span></p>"
        },
        {
          "id": 26016,
          "text": "<p><span style=\"font-size:12.0pt;\">Oral vitamin D3 is given along with oral calcium</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 60-year-old postmenopausal female patient with a history of Colle's fracture comes to the outpatient department complaining of lower back pain. After undergoing a bone density test, her T score is found to be -2.5. Which of the following statements about the management of her condition is incorrect? (NEET PG 2021)</span></p>",
      "unique_key": "Q6183526",
      "question_audio": null,
      "question_video": null,
      "map_id": 13400648,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Bisphosphonates are not given for more than a year</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This question deals with osteoporotic post-menopausal female, who has a history of fracture as well.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Bisphosphonates which act by inhibiting the bone resorption by the osteoclasts form the first line of treatment in this patient. Bisphosphonates are DOC for Osteoporosis (Steroid induced, post-menopausal and due to any reason). These are indicated for 5 years and then a drug holiday of 2-3 years is given to avoid adverse effects (increased risk of bone fractures and osteonecrosis of mandible). These can be repeated for another 5 years after drug holiday.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Teriparatide can be given along with bisphosphonates: </strong>Teriparatide is a parathyroid hormone analog that stimulates bone formation by increasing osteoblast activity. It is particularly useful in patients with severe osteoporosis and a history of fractures. It can be started before bisphosphonates in certain cases.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Calcium requirement is 1200 mg per day: </strong>The recommended daily intake of calcium for postmenopausal women is around 1200 mg. This helps maintain bone density and prevent further bone loss.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Oral vitamin D3 is given along with oral calcium: </strong>Supplementation with oral vitamin D3 (cholecalciferol) along with calcium is essential to ensure proper calcium absorption and to maintain bone health. The recommended dose of vitamin D3 is typically around 800 IU per day.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Bisphosphonates are recommended for up to 5 years, not just one year, in the treatment of osteoporosis in postmenopausal women.</span></p>",
      "correct_choice_id": 26014,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9945,
      "choices": [
        {
          "id": 39746,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 2</span></p>"
        },
        {
          "id": 39747,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 4</span></p>"
        },
        {
          "id": 39748,
          "text": "<p><span style=\"font-size:12.0pt;\">2, 3</span></p>"
        },
        {
          "id": 39749,
          "text": "<p><span style=\"font-size:12.0pt;\">All of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">All of the following statements about proto-oncogenes are true except?</span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">(AIIMS MAY 2021)</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">BRCA1 is an oncogene.</span></li><li><span style=\"font-size:12.0pt;\">HER2neu is amplified only in a fraction of breast cancer.</span></li><li><span style=\"font-size:12.0pt;\">EGFR (+) is seen in non-small cell lung cancer.</span></li><li><span style=\"font-size:12.0pt;\">N-MYC is a tumor suppressor gene.</span></li></ol>",
      "unique_key": "Q7761930",
      "question_audio": null,
      "question_video": null,
      "map_id": 13400649,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.</strong>&nbsp;<strong>B) 1, 4</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Statement 1: BRCA1 is an oncogene.</strong></span></p><p><br><span style=\"font-size:12.0pt;\">This is <strong>false</strong>. BRCA1 is not an oncogene; it is a <strong>tumor suppressor gene</strong>. Mutations in BRCA1 are associated with an increased risk of breast and ovarian cancers, but its normal function is to help repair DNA damage, thereby preventing cancer formation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Statement 4: N-MYC is a tumor suppressor gene.</strong></span></p><p><br><span style=\"font-size:12.0pt;\">This is <strong>false</strong>. N-MYC is not a tumor suppressor gene; it is a <strong>proto-oncogene</strong>. N-MYC is involved in the regulation of cell growth and division. Amplification of the N-MYC gene is commonly seen in neuroblastoma and small-cell carcinoma of the lung.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Statement 2: HER2neu is amplified only in a fraction of breast cancer.</strong></span></p><p><br><span style=\"font-size:12.0pt;\">This is <strong>true</strong>. HER2 (also known as ERBB2) is a proto-oncogene that is amplified in approximately 15-20% of breast cancers. This amplification leads to overexpression of the HER2 protein, which promotes cell proliferation and survival.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Statement 3: EGFR (+) is seen in non-small cell lung cancer.</strong></span></p><p><br><span style=\"font-size:12.0pt;\">This is <strong>true</strong>. EGFR (Epidermal Growth Factor Receptor) is often overexpressed or mutated in non-small cell lung cancer (NSCLC), leading to uncontrolled cell growth.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">BRCA1 is a tumor suppressor gene (involved in DNA repair) and N-MYC is a proto-oncogene (associated with development of neuroblastoma).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/10/screenshot-2023-11-10-185925.jpg\" alt=\"\" width=\"1000\" height=\"1003\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref: Robbins pathologic basis of disease 8<sup>th</sup> edition 521-528</strong></span></p>",
      "correct_choice_id": 39747,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11485,
      "choices": [
        {
          "id": 45906,
          "text": "<p><span style=\"font-size:12.0pt;\">22 mmol/L</span></p>"
        },
        {
          "id": 45907,
          "text": "<p><span style=\"font-size:12.0pt;\">10 mmol/L</span></p>"
        },
        {
          "id": 45908,
          "text": "<p><span style=\"font-size:12.0pt;\">16 mmol/L</span></p>"
        },
        {
          "id": 45909,
          "text": "<p><span style=\"font-size:12.0pt;\">12 mmol/L</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Calculate the anion gap from the following values: Na+ = 137 mmol/L; K+ = 4 mmol/L; CI- =100 mmol/L; HCO3- = 15 mmol/L? (AIIMS MAY 2019)</span></p>",
      "unique_key": "Q4520040",
      "question_audio": null,
      "question_video": null,
      "map_id": 13400650,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) 22 mmol/L</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">AG = (Sum of cation) - (Sum of anion)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">AG = (Na - (HCO3 + CL))</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">AG = 137 – 115 = 22 mmol/L</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Note:&nbsp;</strong>Normal AG ~ 12</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/21/picture49.jpg\" alt=\"\" width=\"1000\" height=\"526\"></span></p>",
      "correct_choice_id": 45906,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10379,
      "choices": [
        {
          "id": 41482,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Environmental enteropathy</span></span></span></p>"
        },
        {
          "id": 41483,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Celiac disease</span></span></span></p>"
        },
        {
          "id": 41484,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Whipple&#39;s disease</span></span></span></p>"
        },
        {
          "id": 41485,
          "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Chronic pancreatitis</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 20-year-old patient presented to the clinic with a history of malabsorption, diarrhea, and poor appetite. Duodenal biopsy of the patient showed crypt hyperplasia, villi atrophy, and CD8+ cells in lamina propria. What is the most probable diagnosis? (NEET PG 2020)</span></span></p>",
      "unique_key": "Q2314349",
      "question_audio": null,
      "question_video": null,
      "map_id": 13400651,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B) Celiac disease </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The clinical presentation and histopathological findings point to celiac disease.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Celiac disease is sometimes referred to as celiac sprue or gluten-sensitive enteropathy. In genetically predisposed individuals, it is an immune-mediated enteropathy triggered by the consumption of gluten-containing cereals such as <strong>Barley, Rye, Oat &amp; Wheat (BROW)</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Almost all celiac disease patients have the class II <strong>HLADQ2 or HLA-DQ8 allele.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Histopathology:&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Increased numbers of <strong>intraepithelial CD8+ T lymphocytes</strong> (intraepithelial lymphocytosis), <strong>crypt hyperplasia</strong>, and <strong>villous atrophy</strong> characterize the histopathology.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/16_jyjVm3Q.jpg\" style=\"height:315px; width:602px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Prior to biopsy, noninvasive serologic tests are usually performed. The presence of IgA antibodies to <strong>tissue transglutaminase or IgA</strong> or IgG antibodies to deamidated gliadin is the most sensitive test. <strong>Anti-endomysial antibodies are more specific than other antibodies but less sensitive</strong>.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Clinical features: -</span></strong></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Malabsorption syndrome&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">with chronic refractory <strong>anemia,</strong> chronic diarrhea, bloating, abdominal pain, and marked weight loss. A characteristic itchy, blistering skin lesion, <strong>dermatitis herpetiformis</strong>, can be present in as many as 10% of patients, and the incidence of lymphocytic gastritis and <strong>lymphocytic colitis</strong> is also increased.</span></span></span></li>\r\n\t\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Enteropathy associated T cell lymphoma</span></strong></span></span></li>\r\n\t\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Small intestinal adenocarcinoma</span></strong></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Treatment &ndash; <strong>Gluten free diet </strong>results in symptomatic improvement for most patients, but a gluten-free diet may also reduce the risk of long-term complications including anemia, female infertility, osteoporosis, and cancer.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">DAPSONE&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">for dermatitis herpetiformis.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Environmental enteropathy:&nbsp;</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Environmental enteropathy / tropical sprue is seen in tropical areas with poor sanitation. It is believed to be caused by one or more infectious agents <strong>that respond to antibiotics</strong>. Mucosa shows variable villous atrophy. Folic acid and B12 deficiency is common.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Whipple&#39;s disease:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Whipple&#39;s disease is a multisystemic disease caused by T. whipplei. Small intestinal biopsy shows PAS-positive macrophages (see image below).</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/19_m0TNFkQ.jpg\" style=\"height:266px; width:400px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Chronic pancreatitis:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Causes malabsorption due to exocrine pancreatic insufficiency. Not associated with the specific histopathological features seen in celiac disease.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Celiac disease is characterized by malabsorption, diarrhea, poor appetite, crypt hyperplasia, villous atrophy, and increased intraepithelial CD8+ T lymphocytes. It is diagnosed by serologic tests and confirmed with a duodenal biopsy. Treatment includes a strict gluten-free diet.</span></span></span></p>",
      "correct_choice_id": 41483,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20929,
      "choices": [
        {
          "id": 83680,
          "text": "<p>Low calcium</p>"
        },
        {
          "id": 83681,
          "text": "<p>Defective collagen formation</p>"
        },
        {
          "id": 83682,
          "text": "<p>Inhibition of clotting factors</p>"
        },
        {
          "id": 83683,
          "text": "<p>Increased keratinization of epithelium</p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\">A patient presenting with bleeding gums and easy bruisability was diagnosed with scurvy. What is the biochemical basis of scurvy?(NEET PG 2023)</p>",
      "unique_key": "Q5709822",
      "question_audio": null,
      "question_video": null,
      "map_id": 13400652,
      "difficulty_level": "beginner",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Ans. B) Defective collagen formation</strong></p><p>&nbsp;</p><p>Scurvy is a condition caused by a deficiency of vitamin C (ascorbic acid), which is essential for the hydroxylation of proline and lysine residues in the synthesis of collagen. Collagen is a crucial protein for the structural integrity of connective tissues, including blood vessels, skin, and gums. In the absence of sufficient vitamin C, collagen synthesis is impaired, leading to weakened blood vessels, bleeding gums, and easy bruising..</p><p>&nbsp;</p><p><strong>Other Options:</strong></p><p>&nbsp;</p><p><strong>Option A.&nbsp;</strong>Low calcium levels do not cause scurvy; they may contribute to other clinical conditions like Muscle cramps and stiffness, Tingling and Numbness, Tetany.</p><p>&nbsp;</p><p><strong>Option C.&nbsp;</strong>Vitamin K deficiency leads to the inhibition of clotting factors and cause bleeding tendencies.</p><p>&nbsp;</p><p><strong>Option D.&nbsp;</strong>Vitamin A deficiency causes hyperkeratosis and epithelial changes, such as xerosis and Bitot's spots, and night blindness.</p><p>&nbsp;</p><p><strong>Educational Objective:</strong></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/03/screenshot-2024-06-03-092725.jpg\" alt=\"\" width=\"1000\" height=\"869\"></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/07/10/picture20.jpg\" alt=\"\" width=\"700\" height=\"160\"></p>",
      "correct_choice_id": 83681,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54662,
      "choices": [
        {
          "id": 218113,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Bag and mask ventilation with oxygen inlet</span></span></span></p>"
        },
        {
          "id": 218114,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Face mask</span></span></span></p>"
        },
        {
          "id": 218115,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Tubing near mouth and nose</span></span></span></p>"
        },
        {
          "id": 218116,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Bag and mask ventilation without oxygen inlet</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Which of the following is not a method of administering free-flow oxygen in a neonate?&nbsp;</span></span></span>&nbsp;(INICET MAY 2024)</p>",
      "unique_key": "Q8833416",
      "question_audio": null,
      "question_video": null,
      "map_id": 13400673,
      "difficulty_level": "intermediate",
      "subjects_id": [
        13
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans.&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">D) Bag and mask ventilation without oxygen inlet</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Free-flow oxygen refers to the administration of oxygen without the need for positive pressure ventilation. It is typically used to provide supplemental oxygen to neonates who are breathing spontaneously.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Bag and mask ventilation with oxygen inlet</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This method allows oxygen to flow freely into the mask and can provide free-flow oxygen.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Face mask</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Using a face mask can administer free-flow oxygen effectively.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Tubing near mouth and nose</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Placing oxygen tubing near the mouth and nose is a common method to deliver free-flow oxygen.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">However, <strong>bag and mask ventilation without oxygen inlet</strong> does not provide a means for oxygen to flow freely. This method relies on positive pressure ventilation, where the bag is squeezed to push air (and oxygen if connected) into the neonate&#39;s lungs, not allowing for the passive flow of oxygen.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12pt\"><strong>Option</strong>&nbsp;</span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>A</strong>. <strong>Bag and mask ventilation with oxygen inlet</strong>: This method allows oxygen to flow through the inlet, providing free-flow oxygen.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12pt\"><strong>Option</strong>&nbsp;</span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>B</strong>. <strong>Face mask</strong>: A face mask can be used to deliver free-flow oxygen effectively.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12pt\"><strong>Option</strong>&nbsp;</span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>C</strong>. <strong>Tubing near mouth and nose</strong>: This is a standard method for administering free-flow oxygen to neonates.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Free-flow oxygen can be administered using methods that allow passive flow of oxygen, such as a face mask or tubing near the mouth and nose. Bag and mask ventilation without an oxygen inlet does not allow for free-flow oxygen administration.</span></span></span></p>",
      "correct_choice_id": 218116,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7020,
      "choices": [
        {
          "id": 28048,
          "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&alpha;1 agonist and &beta;1 agonist</span></span></span></span></span></p>"
        },
        {
          "id": 28049,
          "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">﻿﻿﻿M2 agonist and M3 agonist</span></span></span></span></span></p>"
        },
        {
          "id": 28050,
          "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">﻿﻿﻿&alpha; 1 antagonist and &beta;2 agonist</span></span></span></span></span></p>"
        },
        {
          "id": 28051,
          "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\">﻿﻿﻿<span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&beta;1 agonist and &beta;2 agonist</span></span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-family:Helvetica,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The following table gives BP values before and after administration of drug &#39;X&#39;. What would be the probable mechanism of action of drug &#39;X&#39;?</span></span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> (AIIMS MAY 2017)</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/30/screenshot-2024-09-30-150657.jpg\" style=\"height:296px; width:687px\" /></span></span></p>",
      "unique_key": "Q8253266",
      "question_audio": null,
      "question_video": null,
      "map_id": 13400674,
      "difficulty_level": "difficult",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D. <span style=\"font-family:Helvetica,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&beta;1 agonist and &beta;2 agonist</span></strong></span></span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The drug&#39;s likely mechanism of action is &beta;1 and &beta;2 agonism.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Due to its action on &beta;1 receptors, there is an increase in the HR of the patient and also of the SBP (Increase in HR leads to an increase in the CO upto a certain extent). The agonistic action on the &beta;2 receptors causes vasodilation and leads to a fall in the DBP.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<h3><span style=\"font-size:13.5pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></h3>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option </span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A.</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&alpha;1 agonist and &beta;1 agonist</span></strong>: &alpha;1 agonists typically cause vasoconstriction, which would increase both SBP and DBP. This does not align with the observed decrease in DBP.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option </span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">B. <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">M2 agonist and M3 agonist</span></strong></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: M2 and M3 receptor agonism would likely lead to bradycardia and increased gastrointestinal motility, respectively. They do not explain the observed increase in HR and SBP, nor the decrease in DBP.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option </span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">C. <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&alpha;1 antagonist and &beta;2 agonist</span></strong></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: While &alpha;1 antagonism could contribute to a decrease in DBP through vasodilation, it would not typically cause an increase in SBP and HR, which are more specifically associated with &beta;1 agonism.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The combination of increased systolic blood pressure, decreased diastolic blood pressure, and increased heart rate suggests that drug &#39;X&#39; acts as a &beta;1 and &beta;2 agonist, leading to increased cardiac output and vasodilation.</span></span></p>",
      "correct_choice_id": 28051,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "DiagnosisBased",
        "Factual",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11362,
      "choices": [
        {
          "id": 45414,
          "text": "<p><span style=\"font-size:12.0pt;\">Obstructive jaundice</span></p>"
        },
        {
          "id": 45415,
          "text": "<p><span style=\"font-size:12.0pt;\">Hemolytic jaundice</span></p>"
        },
        {
          "id": 45416,
          "text": "<p><span style=\"font-size:12.0pt;\">Hepatic jaundice</span></p>"
        },
        {
          "id": 45417,
          "text": "<p><span style=\"font-size:12.0pt;\">Prehepatic jaundice</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Laboratory investigations of a patient being evaluated for jaundice show elevated bilirubin and alkaline phosphatase levels. Levels of the remaining liver enzymes are normal. What is the likely diagnosis? (Neet pg 2022)</span></p>",
      "unique_key": "Q4452205",
      "question_audio": null,
      "question_video": null,
      "map_id": 13400675,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A. Obstructive jaundice</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The laboratory findings indicate elevated bilirubin and alkaline phosphatase levels while other liver enzymes are normal. This pattern is most consistent with <strong>obstructive jaundice.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In this condition, there is an obstruction in the bile ducts that prevents bile from being excreted into the intestine, leading to an accumulation of conjugated bilirubin in the blood. Alkaline phosphatase is typically elevated in conditions that involve cholestasis (impaired bile flow), which is characteristic of obstructive jaundice.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Hemolytic jaundice</strong>: This type of jaundice is caused by the excessive breakdown of red blood cells, leading to elevated levels of unconjugated bilirubin. Alkaline phosphatase levels remain normal in hemolytic jaundice.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Hepatic jaundice</strong>: Hepatic jaundice occurs due to liver cell damage, which impairs the liver's ability to process and excrete bilirubin. This condition typically shows elevated transaminases (ALT, AST), not just alkaline phosphatase.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Prehepatic jaundice</strong>: This term is often used interchangeably with hemolytic jaundice, where the problem lies before the bilirubin reaches the liver. Elevated unconjugated bilirubin and normal alkaline phosphatase levels are seen in prehepatic jaundice.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In cases where laboratory investigations reveal elevated bilirubin and alkaline phosphatase with normal other liver enzymes, obstructive jaundice should be considered as the most likely diagnosis.</span></p>",
      "correct_choice_id": 45414,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "InvestigationBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14834,
      "choices": [
        {
          "id": 59297,
          "text": "<p><span style=\"font-size:12.0pt;\">Drug resistant TB</span></p>"
        },
        {
          "id": 59298,
          "text": "<p><span style=\"font-size:12.0pt;\">Cold abscess without neurological involvement</span></p>"
        },
        {
          "id": 59299,
          "text": "<p><span style=\"font-size:12.0pt;\">Evolving cauda equina</span></p>"
        },
        {
          "id": 59300,
          "text": "<p><span style=\"font-size:12.0pt;\">Doubtful diagnosis</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Indications for surgery (including biopsy) in a patient with Potts spine are all except: (</span>INICET May 2020)</p>",
      "unique_key": "Q9921744",
      "question_audio": null,
      "question_video": null,
      "map_id": 13400676,
      "difficulty_level": "intermediate",
      "subjects_id": [
        15
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Cold abscess without neurological involvement</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>POTT’S SPINE</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Like tuberculosis of the bones and joints elsewhere in the body, TB of the spine is always secondary.</span></li><li><span style=\"font-size:12.0pt;\">The tubercular spread to spine usually takes place from Lungs &gt; lymph nodes.</span></li><li><span style=\"font-size:12.0pt;\">The bacteria reach the spine via the hematogenous route, from the lungs or lymph nodes.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Types of vertebral tuberculosis:</strong></span></li></ul><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/11/screenshot-2024-01-11-102222.jpg\" alt=\"\" width=\"1000\" height=\"483\"></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/11/50.jpg\" alt=\"\" width=\"500\" height=\"283\"></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Clinical features:</strong></span><span style=\"font-size:11pt;\">&nbsp;</span><ul><li><span style=\"font-size:12.0pt;\"><strong>Back pain, </strong>usually minimal, is the <strong>commonest and </strong>1st symptom.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Tenderness&nbsp;</strong>is the <strong>earliest sign</strong>.</span></li><li><span style=\"font-size:12.0pt;\">Paravertebral muscle spasm resulting in stiffness in the affected region is a constant early finding. The spine is held rigid. When picking an object up from floor, there is flexion at hips and knees and the spine is in extension – <strong>Coin test</strong></span></li><li><span style=\"font-size:12.0pt;\">Earliest sign of neurological deficit – <strong>increased deep tendon reflexes </strong>or clonus or extensor plantar response.</span></li><li><span style=\"font-size:12.0pt;\">The prominence of 2-3 spinous process, called <strong>angular kyphosis</strong> is commonest in tuberculosis because of 2 contiguous vertebra involved with paradiscal destruction.</span></li><li><span style=\"font-size:12.0pt;\">In the thoracic region, <strong>kyphosis</strong> is most marked because of normal kyphotic curvature.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/11/8.jpg\" alt=\"\" width=\"150\" height=\"345\"></span></p><p>&nbsp;</p><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12.0pt;\">Tuberculosis is the most common cause of <strong>cold abscess</strong>.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Imaging:</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>1. Plain radiograph:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Earliest X-ray feature is loss of Curvature due to paravertebral spasm.</strong></span></li><li><span style=\"font-size:12.0pt;\">Reduction of disc space</span></li><li><span style=\"font-size:12.0pt;\">Vertebral body destruction</span></li><li><span style=\"font-size:12.0pt;\">Paravertebral abscess</span></li><li><span style=\"font-size:12.0pt;\">Widening of mediastinum</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>2. CT scan:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">It may <strong>detect a small paravertebral abscess</strong>, not otherwise seen on plain X-ray; may indicate precisely the extent of destruction of the vertebral body and posterior elements; and <strong>may show a sequestrum or a bony ridge pressing on the cord</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>3. MRI:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Investigation of choice</strong> to evaluate the type and extent of compression of the cord.</span></li><li><span style=\"font-size:12.0pt;\">It also shows condition of the underlying neural tissues, and thus helps in predicting the prognosis in a particular case.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/11/51.jpg\" alt=\"\" width=\"500\" height=\"339\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>4. Biopsy:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>CT guided needle biopsy</strong>, or an open biopsy may be required in a case with doubtful diagnosis.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Stages of TB Spine with Neural Deficit:</strong></span></li></ul><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/11/screenshot-2024-01-11-102436.jpg\" alt=\"\" width=\"1000\" height=\"296\"></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Treatment:</strong></span><ul><li><span style=\"font-size:12.0pt;\"><strong>Middle path regimen</strong> is used in India</span></li><li><span style=\"font-size:12.0pt;\">Treatment is done with <strong>antitubercular therapy (ATT), spinal brace and rest</strong>.</span></li><li><span style=\"font-size:12.0pt;\">Patient is followed on with complete neural examination and if progress is good then continued on nonoperative management but if indications of surgery exist then, surgery needs to be done.</span><br>&nbsp;</li></ul></li><li><span style=\"font-size:12.0pt;\"><strong>Stage-wise Treatment:</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/11/screenshot-2024-01-11-102538.jpg\" alt=\"\" width=\"1000\" height=\"362\"></strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>ATT:</strong></span><span style=\"font-size:11pt;\">&nbsp;</span><ul><li><span style=\"font-size:12.0pt;\"><strong>Rifampicin is always a part of all regimens</strong>.</span></li><li><span style=\"font-size:12.0pt;\">Minimum duration is 9–12 months in spinal TB and may be given up to 18–24 months depending upon clinical, radiological (MRI) and hematological (ESR) healing (in non-spinal TB the duration of ATT is 6 months–1 year).|</span><br>&nbsp;</li></ul></li><li><span style=\"font-size:12.0pt;\"><strong>Indications of surgery in any disease of spine</strong>:</span><ol><li><span style=\"font-size:12.0pt;\">Bowel bladder involvement</span></li><li><span style=\"font-size:12.0pt;\">Deterioration in neural or clinical status on treatment</span></li><li><span style=\"font-size:12.0pt;\">No improvement in neural or clinical status after conservative trial of 3-4 weeks</span></li><li><span style=\"font-size:12.0pt;\">Paravertebral abscess</span></li><li><span style=\"font-size:12.0pt;\">Spine instability due to kyphotic deformity (kyphotic angles 50-60° or more which is likely to progress)</span></li><li><span style=\"font-size:12.0pt;\">Pott’s spine resistant to current anti-tuberculosis drugs</span></li><li><span style=\"font-size:12.0pt;\">To prevent/treat complications like late-onset paraplegia</span><br>&nbsp;</li></ol></li><li><span style=\"font-size:12.0pt;\">Surgical options for most of the cases are anterior decompression + bone grafting or anterolateral decompression + bone grafting and both have similar success rates.</span></li><li><span style=\"font-size:12.0pt;\">Hong Kong operation is also carried out for Pott’s spine.</span></li><li><span style=\"font-size:12.0pt;\">Structures removed in anterolateral decompression are part of rib, one side transverse process, one pedicle and small part of vertebral body (intercostal nerves are exposed).</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/11/52.jpg\" alt=\"\" width=\"500\" height=\"308\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Structures removed in anterolateral decompression</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Note:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Posterior structures like <strong>lamina are never removed in tuberculosis</strong> because disease destroys anteriorly and if surgeon destroys posteriorly then there will be instability.</span></li><li><span style=\"font-size:12.0pt;\">These surgeries are carried out in <strong>right lateral position</strong> (right side down and left side up) approaching the spine from left side as the vessel handled is aorta on left side which is thick muscular vessel with more resilience to handling pressure as compared to vena cava on right side which is friable to handle.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Prognostic Factors:</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/11/screenshot-2024-01-11-103114.jpg\" alt=\"\" width=\"1000\" height=\"691\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/11/53.jpg\" alt=\"\" width=\"800\" height=\"227\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Presence of cold abscess without any neurological involvement is not an indication for biopsy or surgical treatment of Pott’s spine.</span></li><li><span style=\"font-size:12.0pt;\">Neurological involvement which is deteriorating with time is an important indication for surgical intervention.</span></li></ul>",
      "correct_choice_id": 59298,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "CriteriaBased",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11259,
      "choices": [
        {
          "id": 45002,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Stop oral methotrexate and start parenteral methotrexate</span></span></span></span></p>"
        },
        {
          "id": 45003,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Add sulfasalazine and hydroxychloroquine</span></span></span></span></p>"
        },
        {
          "id": 45004,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Continue corticosteroids and methotrexate</span></span></span></span></p>"
        },
        {
          "id": 45005,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Start only anti-TNF alpha agents</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient with rheumatoid arthritis is being treated with methotrexate and low-dose corticosteroids for the past 4 months. However, the disease is still progressing. What would be your recommendation for the further management of this patient? (NEET PG 2019)</span></span></p>",
      "unique_key": "Q9017136",
      "question_audio": null,
      "question_video": null,
      "map_id": 13400677,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. Add sulfasalazine and hydroxychloroquine</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Adding sulfasalazine and hydroxychloroquine to the treatment regimen for a patient with rheumatoid arthritis who is not responding adequately to methotrexate and low-dose corticosteroids is a sound strategy. This approach follows the principle of combining different disease-modifying antirheumatic drugs (DMARDs) to achieve better disease control. Both sulfasalazine and hydroxychloroquine are DMARDs that work by different mechanisms to reduce inflammation and slow disease progression in rheumatoid arthritis.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Stop oral methotrexate and start parenteral methotrexate:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">While switching to parenteral administration can increase the effectiveness of methotrexate for some patients, it might not be sufficient alone if the disease is still progressing.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Continue corticosteroids and methotrexate:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Continuing the same treatment without modification is not advisable if the disease is actively progressing, as this indicates that the current regimen is insufficient.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Start only anti-TNF alpha agents:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">While anti-TNF agents are effective for many patients, they are typically used after trying combination DMARD therapy, especially in cases not severe enough to warrant immediate biologic therapy.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">When a patient with rheumatoid arthritis does not respond adequately to initial therapy with methotrexate and corticosteroids, the addition of other DMARDs such as sulfasalazine and hydroxychloroquine can be beneficial.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Drugs:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Methotrexate:&nbsp;</span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Start 10mg/week &rarr; max 25mg/week along with Folic acid twice/week</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Check ocular fundus before HCQ initiation</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Leflunomide, sulfasalazine other group of drugs.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><em><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sulfasalazine is safe in pregnancy !!</span></span></em></strong></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Symptomatic relief with NSAID and short course corticosteroids.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reference - Harrison/Rheumatoid arthritis/ Chap 358</span></span></strong></p>",
      "correct_choice_id": 45003,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "OlderNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 60497,
      "choices": [
        {
          "id": 241281,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Corynebacterium species</span></span></span></p>"
        },
        {
          "id": 241282,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Streptococcus viridans</span></span></span></p>"
        },
        {
          "id": 241283,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Moraxella lacunata</span></span></span></p>"
        },
        {
          "id": 241284,
          "text": "<p><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Staphylococcus epidermidis</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">A 28-year-old man presents to the ophthalmology clinic with complaints of redness, itching, and irritation at the corners of his eyes for the past week. He reports that these symptoms started gradually and have been worsening, especially after frequent rubbing. He also notices some discharge that accumulates at the corners of his eyes, which sometimes appears foamy. On examination, there is inflammation and mild excoriation at the inner canthi with no signs of corneal involvement. The rest of his ocular exam, including visual acuity and pupillary response, is normal. The physician suspects an infection and plans to start appropriate treatment after identifying the causative organism.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Which of the following is the most likely causative organism?</span></span></span></p>",
      "unique_key": "Q4441804",
      "question_audio": null,
      "question_video": null,
      "map_id": 13400678,
      "difficulty_level": "beginner",
      "subjects_id": [
        8
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Correct Answer </span></strong><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">C. Moraxella lacunata</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Moraxella lacunata is a gram-negative diplobacillus that is the most common causative organism of angular conjunctivitis. This condition is characterized by inflammation, irritation, and a foamy or sticky discharge localized at the inner or outer corners of the eyes. The infection often originates from nasal secretions that spread to the eyes via contaminated hands or objects. Moraxella species are frequently found in the nasal passages of healthy individuals, and when transferred to the eyes, they cause localized canthal inflammation. Treatment typically involves topical antibiotics such as oxytetracycline, with a course lasting 10 to 14 days, which effectively resolves the infection.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option</span></strong> <strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">A. Corynebacterium species:</span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"> While Corynebacterium can cause chronic conjunctivitis, it does not typically present with localized canthal inflammation or foamy discharge. The clinical features seen here are more consistent with angular conjunctivitis caused by Moraxella.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option</span></strong> <strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">B. Streptococcus viridans:</span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"> Streptococcus viridans is generally associated with endophthalmitis or other ocular infections, but it does not typically cause the localized angular inflammation and discharge seen in this patient.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option</span></strong> <strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">D. Staphylococcus epidermidis:</span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"> Staphylococcus epidermidis is a common cause of chronic blepharitis and conjunctivitis, often associated with biofilm formation on eyelid margins or ocular surfaces, rather than the distinct canthal involvement and discharge typical of Moraxella-related angular conjunctivitis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/09/picture4.jpg\" style=\"height:205px; width:300px\" /></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Moraxella lacunata is the leading cause of angular conjunctivitis, characterized by localized inflammation and discharge at the corners of the eyes. The infection spreads from nasal secretions to the eyes via contaminated hands, and the preferred treatment is topical antibiotics, typically oxytetracycline, administered for 10 to 14 days.</span></span></span></p>",
      "correct_choice_id": 241283,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13759,
      "choices": [
        {
          "id": 54997,
          "text": "<p><span style=\"font-size:12.0pt;\">Aconite</span></p>"
        },
        {
          "id": 54998,
          "text": "<p><span style=\"font-size:12.0pt;\">Cerbera thevetia</span></p>"
        },
        {
          "id": 54999,
          "text": "<p><span style=\"font-size:12.0pt;\">Nicotiana tabacum</span></p>"
        },
        {
          "id": 55000,
          "text": "<p><span style=\"font-size:12.0pt;\">Atropa belladonna</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">From the options given below, which of these does not belong to the category of cardiac poison?</span>(INICET MAY 2022)</p>",
      "unique_key": "Q4873972",
      "question_audio": null,
      "question_video": null,
      "map_id": 13401400,
      "difficulty_level": "intermediate",
      "subjects_id": [
        10
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.</strong></span><span style=\"font-size:10.5pt;\"> </span><span style=\"font-size:12.0pt;\"><strong>D. Atropa belladonna&nbsp;</strong></span><span style=\"font-size:10.5pt;\">&nbsp;</span></p><p>&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Atropa belladonna</strong> is not considered a cardiac poison. It is known for its anticholinergic properties and is part of the Solanaceae family, which includes Datura stramonium and Hyoscyamus niger. The active principles in these plants include atropine, hyoscine (scopolamine), and hyoscyamine, which exhibit anticholinergic effects.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Atropa Belladona</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Solanaceae family:&nbsp;</strong>Datura stramonium, Atropa belladonna (deadly nightshade) and Hyoscyamus niger (henbane) all belong to same family Solanaceae</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Anticholinergic alkaloids:&nbsp;</strong>All of these plants have similar alkaloids, and all of these alkaloids have anticholinergic properties.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A<strong>ctive Principles:&nbsp;</strong>Examples of important active principles found in these alkaloids are Atropine, Hyoscine (scopolamine), Hyoscyamine.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Align and symptoms:&nbsp;</strong>All of these have similar anticholinergic sign and symptoms, especially delirium.</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Atropa Belladona have black berries as shown below:</strong></span></p></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/11/screenshot-2024-06-11-131820.png\" alt=\"\" width=\"400\" height=\"322\"></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Aconite:&nbsp;</strong>Aconite is a cardiac poison. It affects the heart by causing arrhythmias and other cardiac disturbances.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Cerbera thevetia:&nbsp;</strong>Cerbera thevetia, also known as yellow oleander, is a well-known cardiac poison. It contains cardiac glycosides that affect the heart's rhythm and contractility.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Nicotiana tabacum:&nbsp;</strong>Nicotiana tabacum, or tobacco, contains nicotine, which has significant effects on the cardiovascular system, including causing hypertension and tachycardia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Cardiac Poisons (Mnemonic: DHONAQ)</strong></span></p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>D</strong>igitalis Purpurea (Digitalis)</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>H</strong>CN</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>O</strong>leander (Kaner):&nbsp;</span></p></li></ul><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &gt; White Oleander (Nerium Odorum)</span></p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &gt; Yellow Oleander (Cerebra Thevetia)</span></p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>N</strong>icotiana Tobaccum (Nicotine, Tobacco)</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>A</strong>conite (Monk’s Hood, Mitha Zaher)</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Q</strong>uinine (Cinchona Plant)</span></p></li></ul>",
      "correct_choice_id": 55000,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3673,
      "choices": [
        {
          "id": 14671,
          "text": "<p><span style=\"font-size:12.0pt;\">Mature dendritic cells</span></p>"
        },
        {
          "id": 14672,
          "text": "<p><span style=\"font-size:12.0pt;\">Follicular dendritic cells</span></p>"
        },
        {
          "id": 14673,
          "text": "<p><span style=\"font-size:12.0pt;\">B lymphocytes</span></p>"
        },
        {
          "id": 14674,
          "text": "<p><span style=\"font-size:12.0pt;\">NK cell</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is the most potent stimulator of naive T-cells?</span><span style=\"font-size:10.5pt;\"> (</span><span style=\"font-size:12.0pt;\">INICET</span><span style=\"font-size:10.5pt;\"> </span><span style=\"font-size:12.0pt;\">NOV 2018)</span></p>",
      "unique_key": "Q3324362",
      "question_audio": null,
      "question_video": null,
      "map_id": 13401921,
      "difficulty_level": "intermediate",
      "subjects_id": [
        6
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Mature dendritic cells</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Mature dendritic cells are the most potent stimulator of naive T cells as they possess higher levels</strong> <strong>of MHC-II</strong>. They also have costimulatory membrane proteins which are required for activation of T cells.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;B. Follicular dendritic cells</strong> are functionally different from dendritic cells. They are <strong>not antigen-presenting-cells and do not activate naive T cells.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/30/1-micro-19.jpg\" alt=\"\" width=\"700\" height=\"961\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. B lymphocytes:</strong> While B cells can act as antigen-presenting cells, they are not as effective as dendritic cells in stimulating naive T cells. They typically present antigens to already activated T cells rather than naive ones.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. NK cell:</strong> Natural killer (NK) cells are involved in the innate immune response and do not function as antigen-presenting cells. They are responsible for recognizing and killing virally infected cells and tumor cells without the need for antigen presentation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">Mature dendritic cells are the most potent stimulators of naive T cells due to their high levels of MHC-II and costimulatory molecules.</span></p>",
      "correct_choice_id": 14671,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16095,
      "choices": [
        {
          "id": 64340,
          "text": "<p><span style=\"font-size:12.0pt;\">Foramen lacerum</span></p>"
        },
        {
          "id": 64341,
          "text": "<p><span style=\"font-size:12.0pt;\">Foramen magnum</span></p>"
        },
        {
          "id": 64342,
          "text": "<p><span style=\"font-size:12.0pt;\">Foramen rotundum</span></p>"
        },
        {
          "id": 64343,
          "text": "<p><span style=\"font-size:12.0pt;\">Foramen jugulare</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which skull foramen is formed by 3 bones?</span>(INICET NOV 2022)</p>",
      "unique_key": "Q6209023",
      "question_audio": null,
      "question_video": null,
      "map_id": 13401922,
      "difficulty_level": "intermediate",
      "subjects_id": [
        3
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A. Foramen lacerum</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The foramen lacerum is a triangular-shaped foramen located in the skull base. It is largely filled with cartilage in a living individual and serves as a landmark rather than a conduit for significant neurovascular structures (though some smaller emissary veins and nerves might pass through). Importantly, the internal carotid artery courses superiorly to this foramen but doesn't pass through it. The foramen lacerum is bordered by three bones:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Petrous part of the temporal bone:</strong> This bone forms the posterior and medial aspect of the foramen lacerum.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Sphenoid bone:</strong> The <strong>greater wing</strong> of the sphenoid bone forms the anterior and lateral aspect of the foramen lacerum.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Basilar part of the occipital bone:</strong> The basilar part of the occipital bone forms the posterior and medial aspect of the foramen lacerum.</span></li></ul><p>&nbsp;</p><p style=\"margin-left:24px;\"><span style=\"font-size:12.0pt;\">The foramen lacerum is covered by a fibrous membrane, which makes it difficult to see and access.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/19/niv-hfnc-14.jpg\" alt=\"\" width=\"500\" height=\"667\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Foramen magnum:</strong> The foramen magnum is the largest foramen of the skull and is located in its base. Through it pass the medulla oblongata (which becomes the spinal cord as it exits the skull), the vertebral arteries, spinal parts of the accessory nerves, and the anterior and posterior spinal arteries. It is formed entirely by the occipital bone.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Foramen rotundum:</strong> The foramen rotundum is located in the greater wing of the sphenoid bone. Through this foramen, the maxillary branch of the trigeminal nerve (V2) exits the cranial cavity to enter the pterygopalatine fossa. It is formed solely by the sphenoid bone.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Foramen jugulare (jugular foramen):</strong> The jugular foramen is a large irregular opening located between the petrous part of the temporal bone and the occipital bone. This foramen transmits the internal jugular vein and several cranial nerves: the glossopharyngeal (IX), vagus (X), and accessory (XI) nerves. It is formed by two bones:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Anterolaterally: the petrous part of the temporal bone.</span></li><li><span style=\"font-size:12.0pt;\">Posteromedially: the occipital bone.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"background-color:white;color:#0d0d0d;font-size:11.0pt;\">The foramen lacerum's formation by three bones (the petrous part of the temporal bone, greater wing of the sphenoid bone, and basilar part of the occipital bone) makes it unique among the foramina at the base of the skull. Understanding its anatomical context and relations is crucial for interpreting imaging and planning surgeries involving the cranial base.</span></p>",
      "correct_choice_id": 64340,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5950,
      "choices": [
        {
          "id": 23770,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 2, 3</span></p>"
        },
        {
          "id": 23771,
          "text": "<p><span style=\"font-size:12.0pt;\">2, 3, 4</span></p>"
        },
        {
          "id": 23772,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 3, 4</span></p>"
        },
        {
          "id": 23773,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 2, 4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A teenage girl presented with irregular cycles and increased facial hair. Her ovaries showed increased volume. Which of the following are used in the first line treatment?&nbsp;</span>(INICET MAY 2021)</p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Laparoscopic ovarian drilling</span></li><li><span style=\"font-size:12.0pt;\">Anti-androgens</span></li><li><span style=\"font-size:12.0pt;\">Lifestyle modifications</span></li><li><span style=\"font-size:12.0pt;\">Combined oral contraceptive pills</span></li></ol>",
      "unique_key": "Q1176513",
      "question_audio": null,
      "question_video": null,
      "map_id": 13401923,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) 2, 3, 4</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">The clinical presentation of irregular menstrual cycles and increased facial hair, combined with increased ovarian volume, is suggestive of <strong>polycystic ovarian syndrome (PCOS)</strong>. The first-line treatment options for PCOS typically include:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Anti-androgens</strong> (2): These medications help reduce symptoms related to excess androgens, such as facial hair and acne. Common examples include spironolactone.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Lifestyle modifications</strong> (3): These are crucial for managing PCOS. Weight loss and exercise can improve insulin sensitivity and help regulate menstrual cycles.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Combined oral contraceptive pills</strong> (4): These are used to regulate menstrual cycles, reduce hyperandrogenism symptoms (like hirsutism), and provide endometrial protection.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Laparoscopic ovarian drilling</strong> (1): This is a surgical procedure used to treat PCOS, but it is generally considered a second-line treatment. It is typically performed when medical management fails to achieve the desired results.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">The first-line treatments for PCOS include anti-androgens, lifestyle modifications, and combined oral contraceptive pills.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref: Page no 460, DC Dutta’s Textbook of Gynecology 6<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 23771,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7137,
      "choices": [
        {
          "id": 28516,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Cefixime </span></span></span></p>"
        },
        {
          "id": 28517,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Cefoperazone </span></span></span></p>"
        },
        {
          "id": 28518,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Ceftobiprole </span></span></span></p>"
        },
        {
          "id": 28519,
          "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Ceftazidime&quot;</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient who was receiving warfarin therapy for atrial fibrillation was prescribed a cephalosporin antibiotic to treat a lower respiratory tract infection. He returned to the hospital after developing hemarthrosis. Which of the following cephalosporins is most likely to have caused this? (</span></span>INICET Nov 2021)</p>",
      "unique_key": "Q5320564",
      "question_audio": null,
      "question_video": null,
      "map_id": 13401924,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B. Cefoperazone</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The development of hemarthrosis (bleeding into a joint) in a patient on warfarin therapy, after starting a cephalosporin antibiotic, raises concerns about drug interactions that can potentiate the anticoagulant effect of warfarin. </span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Warfarin inhibits the enzyme Vitamin K Epoxide Reductase (VKOR) which in turn inhibits the gamma carboxylation of Glutamic acid residues of factors II, VII , IX and X. </span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Cefoperazone is a 3<sup>rd</sup> generation cephalosporin that contains methylthiotetrazole (MTT) group. This also inhibits the VKOR enzyme, just like warfarin. Therefore, in a patient who is already on warfarin therapy, this can lead to bleeding manifestations. </span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Cefotetan, Cefamandole are other cephalosporins that contain the MTT group.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">A. Cefixime:</span></strong><span style=\"font-size:12.0pt\"> This is a third-generation cephalosporin and is not known to have a significant interaction with warfarin that would increase the risk of bleeding.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">C. Ceftobiprole:</span></strong><span style=\"font-size:12.0pt\"> As a newer cephalosporin, ceftobiprole is not commonly associated with significant interactions with warfarin that would lead to increased bleeding risk.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">D. Ceftazidime:</span></strong><span style=\"font-size:12.0pt\"> This is another third-generation cephalosporin, and like cefixime, it is not commonly associated with interactions that significantly enhance the anticoagulant effect of warfarin.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cefoperazone</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> is the cephalosporin most likely to cause hemarthrosis in a patient on warfarin therapy due to its MTT group, which can inhibit the VKOR enzyme and potentiate the anticoagulant effects of warfarin. Other cephalosporins like cefixime, ceftobiprole, and ceftazidime do not have this interaction and are less likely to cause such bleeding complications.</span></span></span></p>",
      "correct_choice_id": 28517,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14432,
      "choices": [
        {
          "id": 57689,
          "text": "<p><span style=\"font-size:12.0pt;\">Romovac</span></p>"
        },
        {
          "id": 57690,
          "text": "<p><span style=\"font-size:12.0pt;\">Jackson-Pratt drain</span></p>"
        },
        {
          "id": 57691,
          "text": "<p><span style=\"font-size:12.0pt;\">Minivac</span></p>"
        },
        {
          "id": 57692,
          "text": "<p><span style=\"font-size:12.0pt;\">Corrugated drain</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The instrument given in the image is:</span> <span style=\"font-size:12.0pt;\">(AIIMS NOV 2019)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/06/untitled-664.jpg\" alt=\"\" width=\"400\" height=\"301\"></span></p>",
      "unique_key": "Q1404995",
      "question_audio": null,
      "question_video": null,
      "map_id": 13401925,
      "difficulty_level": "beginner",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Jackson-Pratt drain</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The image displays a Jackson-Pratt (JP) drain, which is a type of closed drainage system used in post-surgical procedures. This device comprises a flexible bulb connected to tubing, creating negative pressure to gently suction fluid from the wound or surgical site. The bulb can be compressed and then sealed to initiate suction, allowing controlled drainage and reducing the risk of infection.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Romovac drain</strong>: Romovac drains are commonly used after various surgical procedures, including abdominal surgeries, breast surgeries, orthopedic surgeries, and others. They are also utilized in the treatment of abscesses and some types of traumatic injuries. They are a closed drainage system.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/06/untitled-665.jpg\" alt=\"\" width=\"306\" height=\"307\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Minivac drain – (Mini in size)</strong>: A closed suction&nbsp;<i><strong>drain</strong></i>&nbsp;is placed under your skin during surgery. This&nbsp;<i><strong>drain</strong></i>&nbsp;removes any blood or other fluids that might build up in this area.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/06/untitled-667.jpg\" alt=\"\" width=\"190\" height=\"281\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Corrugated drain</strong>: Corrugated drains are&nbsp;intended for open passive drainage, used in situations where wounds must be kept open. They are placed directly into the wounds left to heal by secondary intent.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/06/untitled-668.jpg\" alt=\"\" width=\"222\" height=\"131\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective :&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The Jackson-Pratt drain is a closed drainage system that uses gentle suction to remove fluids from surgical sites, helping prevent fluid accumulation and reducing infection risk.</span></p>",
      "correct_choice_id": 57690,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ImageBased",
        "InstrumentsBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 60498,
      "choices": [
        {
          "id": 241285,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Episcleritis</span></span></span></p>"
        },
        {
          "id": 241286,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Anterior uveitis</span></span></span></p>"
        },
        {
          "id": 241287,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Follicular conjunctivitis</span></span></span></p>"
        },
        {
          "id": 241288,
          "text": "<p><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Keratitis</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">A 32-year-old woman presents to the ophthalmology clinic with complaints of redness, tearing, and a mild foreign body sensation in her right eye for the past few days. She reports no significant ocular history but mentions recent symptoms of fever, cough, and anosmia. She has no known allergies or history of eye trauma. Her visual acuity is unaffected, and there is no pain with eye movement. On examination, there is mild conjunctival injection without discharge or chemosis. The ophthalmologist is concerned about the possibility of a systemic viral infection. What is the most common ocular manifestation associated with the suspected viral infection in this patient?</span></span></span></p>",
      "unique_key": "Q3832641",
      "question_audio": null,
      "question_video": null,
      "map_id": 13402026,
      "difficulty_level": "intermediate",
      "subjects_id": [
        8
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Correct Answer: </span></strong><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">C. Follicular conjunctivitis</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Follicular conjunctivitis is the most common ocular manifestation observed in patients with COVID-19. The virus affects the eyes due to the presence of ACE-2 receptors on the cornea and conjunctiva, which act as entry points for SARS-CoV-2. Follicular conjunctivitis appears as mild conjunctival redness with or without discharge, and it can occasionally be the only symptom of COVID-19, highlighting the virus&#39;s potential to impact the eyes. Other ocular symptoms include tearing, itching, and a foreign body sensation, but follicular conjunctivitis remains the predominant ocular finding.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option</span></strong> <strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">A. Episcleritis:</span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"> Episcleritis is a localized, benign inflammation of the episclera often associated with autoimmune conditions rather than viral infections like COVID-19. It presents with mild redness and discomfort, which can be mistaken for conjunctivitis but is less common in COVID-19.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option</span></strong> <strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">B. Anterior uveitis:</span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"> Anterior uveitis is characterized by inflammation of the iris and ciliary body, leading to photophobia, pain, and visual disturbances. It is not commonly associated with COVID-19 and would present with different symptoms such as eye pain and photophobia, unlike the mild conjunctivitis observed.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option</span></strong> <strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">D. Keratitis:</span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"> Keratitis involves inflammation of the cornea and can present with severe pain, photophobia, and vision changes. This condition is not a common manifestation of COVID-19 and typically has more severe symptoms compared to follicular conjunctivitis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Follicular conjunctivitis is the most common ocular manifestation seen in patients with COVID-19. It is crucial for healthcare providers, especially ophthalmologists, to be aware of this presentation and to consider COVID-19 testing in patients with unexplained conjunctival symptoms, including<br />\r\n&nbsp;<br />\r\n<strong>Most common ocular symptoms:</strong> Dry eye or foreign body sensation, redness, tearing, itching, eye pain, and discharge.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Most common ocular manifestation:</span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"> Mild follicular conjunctivitis, which can appear as the only sign and symptom of COVID-19.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Other less frequent ocular complications:</span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"> Hemorrhagic conjunctivitis, dry eye disease, episcleritis, chemosis, and photophobia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Intraocular complications that may occur:</span></strong><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\"> Retinal artery occlusions, hemorrhages, and cotton wool spots caused by complement-mediated thrombotic angiopathy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Patients with conjunctivitis should undergo a nasopharyngeal RT-PCR test for COVID-19 to rule out systemic infection.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:12.0pt\">Physicians and ophthalmologists should exercise caution when examining patients with conjunctivitis and wear eye-protective gear in addition to face masks and other protective devices.</span></span></span><br />\r\n&nbsp;</p>",
      "correct_choice_id": 241287,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11169,
      "choices": [
        {
          "id": 44642,
          "text": "<p><span style=\"font-size:18px;\">Binomial distribution</span></p>"
        },
        {
          "id": 44643,
          "text": "<p><span style=\"font-size:18px;\">Gaussian distribution</span></p>"
        },
        {
          "id": 44644,
          "text": "<p><span style=\"font-size:18px;\">Poisson distribution</span></p>"
        },
        {
          "id": 44645,
          "text": "<p><span style=\"font-size:18px;\">Normal distribution</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:18px;\"><strong>A clinician is conducting a study on the occurrence of a rare disease within a specific population over a certain time period. The disease cases occur independently, and the average rate of occurrence is constant. Which statistical distribution best represents the likelihood of observing a specific number of disease cases within this defined time period? </strong><i><strong>[INICET NOV 2020]</strong></i></span></p>",
      "unique_key": "Q7297895",
      "question_audio": null,
      "question_video": null,
      "map_id": 13402147,
      "difficulty_level": "intermediate",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (c) Poisson distribution</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Poisson Distribution</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">It is a ‘discrete probability distribution’ that expresses the ‘probability of a number of events occurring in a fixed period of time’ (if these events occur with a known average rate and independently of the time since the last event).</span></li><li><span style=\"font-size:18px;\">It can also be used for the number of events in other specified intervals such as distance, area or volume.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option A. Binomial distribution</strong> is used for those events which can only have two possible results given as yes or no / success or failure. It is usually done for finite number of events unlike Poisson’s distribution.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option B. Gaussian distribution and Option D. Normal distribution</strong> is the distribution of values of a quantitative variable such that they are symmetric with respect to a middle value with same mean, median and mode, and then the frequencies taper off rapidly and symmetrically on both sides – ‘bell shaped distribution’.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">The Poisson distribution is used to model the number of rare disease cases occurring independently in a fixed period of time.</span></li></ul>",
      "correct_choice_id": 44644,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4203,
      "choices": [
        {
          "id": 16789,
          "text": "<p>1</p>"
        },
        {
          "id": 16790,
          "text": "<p>2</p>"
        },
        {
          "id": 16791,
          "text": "<p>3</p>"
        },
        {
          "id": 16792,
          "text": "<p>4</p>"
        }
      ],
      "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is wrong regarding primary and secondary immune response? (INICET MAY 2022)</span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/28/screenshot-2024-06-28-140745.png\" style=\"height:205px; width:700px\" /></p>",
      "unique_key": "Q9777006",
      "question_audio": null,
      "question_video": null,
      "map_id": 13402148,
      "difficulty_level": "beginner",
      "subjects_id": [
        6
      ],
      "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. D) 4</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The given statement that antibody affinity is higher in the primary immune response and lower in the secondary immune response is incorrect. The correct comparison should be:</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Primary Immune Response</span></strong><span style=\"font-size:12.0pt\">: This occurs as a result of the first contact with an antigen. It typically involves a longer lag period (4-10 days) before antibodies are produced. The initial antibodies produced are primarily IgM, with lower affinity for the antigen.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Secondary Immune Response</span></strong><span style=\"font-size:12.0pt\">: This occurs as a result of subsequent exposures to the same antigen. It involves a shorter lag period (1-3 days) due to the presence of memory cells. The antibodies produced are primarily IgG, which have higher affinity for the antigen compared to those produced in the primary response. The secondary response is more rapid and robust, producing higher levels of antibodies that persist for a longer period.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/23/untitled-201.jpg\" style=\"height:273px; width:500px\" /></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Lag period</strong>: Correctly identified; the primary immune response has a longer lag period (4-10 days), while the secondary immune response has a shorter lag period (1-3 days).</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Antibody response</strong>: Correctly identified; the secondary immune response is more potent than the primary immune response.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Isotype generated</strong>: Correctly identified; the primary response mainly produces IgM, while the secondary response mainly produces IgG.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational objective</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/28/screenshot-2024-06-28-141229.png\" style=\"height:827px; width:1000px\" /></span></strong></span></span></p>",
      "correct_choice_id": 16792,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6896,
      "choices": [
        {
          "id": 27552,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ranitidine tablet before start of trip</span></span></span></p>"
        },
        {
          "id": 27553,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Dimenhydrinate before start of trip</span></span></span></p>"
        },
        {
          "id": 27554,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Scopolamine patch the night before trip</span></span></span></p>"
        },
        {
          "id": 27555,
          "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Omeprazole the night before and before starts of trip</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">You and your friend plan for a mountain trip for the day after. What medication would you advise him to help with his motion sickness? (</span></span></span>AIIMS Nov 2017)</p>",
      "unique_key": "Q7030456",
      "question_audio": null,
      "question_video": null,
      "map_id": 13402149,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C. Scopolamine patch the night before trip</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Scopolamine is an anticholinergic drug that is highly effective for the prevention and treatment of motion sickness. It works by blocking the muscarinic receptors in the central nervous system, which helps prevent the nausea and vomiting associated with motion sickness.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Transdermal Scopolamine Patch</span></strong><span style=\"font-size:12.0pt\">: The patch is typically applied behind the ear at least 4-5 hours before the trip and can provide continuous relief for up to 72 hours. This makes it highly convenient for trips that may last for several days</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Ranitidine tablet before start of trip: </span></strong><span style=\"font-size:12.0pt\">Ranitidine is a histamine-2 receptor antagonist used to reduce stomach acid production. It is not effective for the prevention of motion sickness.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Dimenhydrinate before start of trip: </span></strong><span style=\"font-size:12.0pt\">Dimenhydrinate (Dramamine) is an antihistamine that can be effective for treating motion sickness, but it requires more frequent dosing compared to the scopolamine patch. It is taken orally and must be dosed every 4-6 hours.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Omeprazole the night before and before start of trip: </span></strong><span style=\"font-size:12.0pt\">Omeprazole is a proton pump inhibitor used to reduce stomach acid production and treat gastroesophageal reflux disease (GERD). It is not effective for preventing motion sickness.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Scopolamine, particularly in the form of a transdermal patch, is the drug of choice for the prevention of motion sickness. The patch should be applied the night before the trip to ensure it is effective in preventing the symptoms of motion sickness. Ranitidine and Omeprazole are not effective. Dimenhydrinate is an anti-histaminic drug which is not as effective as scopolamine.</span></span></span></p>",
      "correct_choice_id": 27554,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}